US20190192750A1 - Hybrid Sealing Tape - Google Patents
Hybrid Sealing Tape Download PDFInfo
- Publication number
- US20190192750A1 US20190192750A1 US16/287,862 US201916287862A US2019192750A1 US 20190192750 A1 US20190192750 A1 US 20190192750A1 US 201916287862 A US201916287862 A US 201916287862A US 2019192750 A1 US2019192750 A1 US 2019192750A1
- Authority
- US
- United States
- Prior art keywords
- adhesive
- sealing
- sealing tape
- pattern
- bonding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000007789 sealing Methods 0.000 title claims abstract description 226
- 239000000853 adhesive Substances 0.000 claims abstract description 162
- 230000001070 adhesive effect Effects 0.000 claims abstract description 162
- 210000001519 tissue Anatomy 0.000 claims abstract description 133
- 239000012945 sealing adhesive Substances 0.000 claims abstract description 110
- 210000002615 epidermis Anatomy 0.000 claims abstract description 67
- 239000010410 layer Substances 0.000 claims description 74
- 230000008878 coupling Effects 0.000 claims description 38
- 238000010168 coupling process Methods 0.000 claims description 38
- 238000005859 coupling reaction Methods 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 30
- 239000012790 adhesive layer Substances 0.000 claims description 13
- 238000002560 therapeutic procedure Methods 0.000 description 36
- 239000012530 fluid Substances 0.000 description 28
- 239000000463 material Substances 0.000 description 17
- 230000001225 therapeutic effect Effects 0.000 description 16
- 206010052428 Wound Diseases 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 239000003522 acrylic cement Substances 0.000 description 12
- 230000008901 benefit Effects 0.000 description 10
- 239000006260 foam Substances 0.000 description 9
- 238000000576 coating method Methods 0.000 description 8
- 230000000670 limiting effect Effects 0.000 description 8
- 239000004814 polyurethane Substances 0.000 description 8
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 229920002635 polyurethane Polymers 0.000 description 7
- 230000007423 decrease Effects 0.000 description 6
- 239000013464 silicone adhesive Substances 0.000 description 6
- 239000000017 hydrogel Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 4
- 210000000416 exudates and transudate Anatomy 0.000 description 4
- 239000000416 hydrocolloid Substances 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229920000954 Polyglycolide Polymers 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 238000007664 blowing Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 239000004633 polyglycolic acid Substances 0.000 description 3
- 229920000098 polyolefin Polymers 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000006261 foam material Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229920006249 styrenic copolymer Polymers 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 0 *C(CCC1)C1C1CCCCCC1 Chemical compound *C(CCC1)C1C1CCCCCC1 0.000 description 1
- IZSJBFPPZGMYJV-ICELGVTBSA-N C(C1CC2)C1C1[C@H]2C2C1CC2 Chemical compound C(C1CC2)C1C1[C@H]2C2C1CC2 IZSJBFPPZGMYJV-ICELGVTBSA-N 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 229920001247 Reticulated foam Polymers 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- JEDYYFXHPAIBGR-UHFFFAOYSA-N butafenacil Chemical compound O=C1N(C)C(C(F)(F)F)=CC(=O)N1C1=CC=C(Cl)C(C(=O)OC(C)(C)C(=O)OCC=C)=C1 JEDYYFXHPAIBGR-UHFFFAOYSA-N 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000009581 negative-pressure wound therapy Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- -1 organogel Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006264 polyurethane film Polymers 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 201000002282 venous insufficiency Diseases 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
-
- A61M1/0088—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00068—Accessories for dressings specially adapted for application or removal of fluid, e.g. irrigation or drainage of wounds, under-pressure wound-therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
- A61F13/0216—Adhesive plasters or dressings having a fluid handling member the fluid handling member being non absorbent, e.g. for use with sub- or over-pressure therapy, wound drainage or wound irrigation systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0246—Adhesive plasters or dressings characterised by the skin adhering layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0246—Adhesive plasters or dressings characterised by the skin adhering layer
- A61F13/025—Adhesive plasters or dressings characterised by the skin adhering layer having a special distribution arrangement of the adhesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0269—Tapes for dressing attachment
-
- A61F13/05—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/58—Adhesives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
- B32B37/12—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by using adhesives
- B32B37/1284—Application of adhesive
- B32B37/1292—Application of adhesive selectively, e.g. in stripes, in patterns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
Definitions
- the present disclosure relates generally to dressings for adhering to a patient, and more particularly, but without limitation, to a hybrid sealing tape having at least two adhesives disposed thereon.
- Negative-pressure therapy may provide a number of benefits, including migration of epithelial and subcutaneous tissues, improved blood flow, and micro-deformation of tissue at a wound site. Together, these benefits can increase development of granulation tissue and reduce healing times.
- a dressing for treating a tissue site with negative pressure may include a tissue interface configured to be positioned adjacent to the tissue site.
- the dressing also may include a sealing member configured to be positioned over the tissue interface and the tissue site to form a sealed environment.
- the dressing further may include one or more sealing tape configured to be coupled to the sealing member and epidermis adjacent to the tissue site.
- the sealing tape each may have a bonding adhesive and a sealing adhesive coupled to a side of each sealing tape.
- a system for treating a tissue site with negative-pressure may include a manifold configured to be positioned adjacent to the tissue site and a drape configured to be positioned over the tissue site and the manifold and configured to seal to tissue adjacent to the tissue site to form a sealed space.
- the system also may include a negative-pressure source configured to provide negative-pressure to the sealed space.
- the system further may include one or more sealing tape configured to be coupled to the drape and epidermis adjacent to the tissue site.
- the sealing tape may each have a bonding adhesive and a sealing adhesive coupled to a side of each sealing tape.
- a manifold may be disposed adjacent to the tissue site.
- the manifold may be covered with a drape and the drape may be sealed to tissue adjacent to the tissue site to form a sealed space.
- a negative-pressure source may be configured to provide negative-pressure to the sealed space.
- One or more sealing tape may be coupled to the drape and epidermis adjacent to the tissue site.
- the sealing tape may each have a bonding adhesive configured to form a bonding coupling and a sealing adhesive configured to form a sealing coupling coupled to a side of the sealing tape.
- a method for manufacturing sealing tape for a negative-pressure system provides a film layer and couples a layer of a bonding adhesive to the film layer.
- the method couples a layer of a sealing adhesive to the bonding layer.
- the method removes portions of the sealing adhesive to form a first pattern and expose the bonding adhesive through the sealing adhesive in a second pattern.
- a method for manufacturing sealing tape for a negative-pressure system is described.
- a film layer may be provided and a bonding adhesive may be disposed on a first portion of the film layer in a first pattern.
- a sealing adhesive may be disposed on a second portion of the film layer in a second pattern.
- the second pattern may be registered with the first pattern so that the first portion and the second portion cover substantially different portions of the film layer.
- FIG. 1A is a schematic diagram (with a portion shown in elevation) of an illustrative embodiment of a system for treating a tissue site on a patient with negative pressure that may be associated with some illustrative embodiments of the system;
- FIG. 1B is a plan view of a portion of the system of FIG. 1A ;
- FIG. 2A is a schematic diagram (with a portion shown in elevation) of another illustrative embodiment of a system for treating a tissue site on a patient with negative pressure;
- FIG. 2B is a plan view of a portion of the system of FIG. 2A ;
- FIG. 3 is an exploded perspective view of a sealing tape that may be used with some embodiments of the systems of FIG. 1A and FIG. 2A ;
- FIG. 4A is a sectional view of a portion of the sealing tape of FIG. 3 with sealing couplings;
- FIG. 4B is a sectional view of the portion of the sealing tape of FIG. 4A with bonding couplings;
- FIG. 5 is an exploded perspective view of a sealing tape that may be used with the systems of FIG. 1A and FIG. 2A ;
- FIG. 6 is a sectional view of a portion of the sealing tape of FIG. 5 proximate to an epidermis;
- FIG. 7 is a sectional view of the portion of the sealing tape of FIG. 6 with sealing couplings
- FIG. 8 is a sectional view of the portion of the sealing tape of FIG. 6 with bonding couplings.
- FIG. 9 , FIG. 10 , FIG. 11 , FIG. 12 , FIG. 13 , FIG. 14 , and FIG. 15 are plan views of illustrative patterns of the sealing tape of FIG. 3 and FIG. 5 .
- FIG. 1A is a sectional view of an example embodiment of a negative-pressure therapy system 100 illustrating details that may be associated with some embodiments for treating a tissue site 102 with negative pressure.
- the negative-pressure therapy system 100 may include a dressing 104 fluidly coupled to a negative-pressure source 106 .
- the negative-pressure source 106 may be fluidly coupled to the dressing 104 by a conduit, such as a tube 112 , and a connector, such as a connector 114 .
- the dressing 104 may generally include a cover or sealing member, such as a drape 108 , and a tissue interface, such as a tissue interface 110 .
- the drape 108 may be attached to an epidermis 116 .
- the drape 108 can substantially prevent the leakage of fluids while allowing vapor to egress through the drape 108 .
- the dressing 104 may include one or more sealing tape 124 coupled to epidermis 116 and the drape 108 .
- components of the negative-pressure therapy system 100 may be coupled directly or indirectly to each other.
- the negative-pressure source 106 may be directly coupled to the connector 114 and indirectly coupled to the tissue interface 110 through the connector 114 .
- Components may be fluidly coupled to each other to provide a path for transferring fluids (i.e., liquid and/or gas) between the components.
- components may be fluidly coupled with a tube, such as the tube 112 , for example.
- a tube is an elongated, cylindrical structure with some flexibility, but the geometry and rigidity may vary.
- components may additionally or alternatively be coupled by virtue of physical proximity, being integral to a single structure, or being formed from the same piece of material. Coupling may also include mechanical, thermal, electrical, or chemical coupling (such as a chemical bond) in some contexts.
- a tissue interface such as the tissue interface 110
- the drape 108 may be sealed to undamaged epidermis peripheral to the tissue site.
- the drape 108 can provide a sealed therapeutic environment 118 proximate to the tissue site 102 .
- the sealed therapeutic environment 118 may be substantially isolated from the external environment, and the negative-pressure source 106 can reduce the pressure in the sealed therapeutic environment 118 .
- Negative pressure applied across the tissue site through a tissue interface in the sealed therapeutic environment 118 can induce macrostrain and microstrain in the tissue site 102 , as well as remove exudates and other fluids from the tissue site. The removed exudates and other fluids can be collected in a container and disposed of properly.
- the fluid mechanics of using a negative-pressure source to reduce pressure in another component or location, such as within a sealed therapeutic environment 118 can be mathematically complex.
- the basic principles of fluid mechanics applicable to negative-pressure therapy are generally well-known to those skilled in the art, and the process of reducing pressure may be described illustratively herein as “delivering,” “distributing,” or “generating” negative pressure, for example.
- tissue site in this context broadly refers to a wound or defect located on or within tissue, including but not limited to, bone tissue, adipose tissue, muscle tissue, neural tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons, or ligaments.
- a wound may include chronic, acute, traumatic, subacute, and dehisced wounds, partial-thickness burns, ulcers (such as diabetic, pressure, or venous insufficiency ulcers), flaps, and grafts, for example.
- tissue site may also refer to areas of tissue that are not necessarily wounded or defective, but are instead areas in which it may be desirable to add or promote the growth of additional tissue.
- tissue site 102 may be a wound that extends through the epidermis 116 , through a dermis 120 , and into subcutaneous tissue 122 .
- Negative pressure generally refers to a pressure less than a local ambient pressure, such as the ambient pressure in a local environment external to the sealed therapeutic environment 118 provided by the drape 108 .
- the local ambient pressure may also be the atmospheric pressure at which a tissue site is located.
- the pressure may be less than a hydrostatic pressure associated with tissue at the tissue site. Unless otherwise indicated, values of pressure stated herein are gauge pressures.
- references to increases in negative pressure typically refer to a decrease in absolute pressure, while decreases in negative pressure typically refer to an increase in absolute pressure.
- a negative-pressure source such as the negative-pressure source 106
- a negative-pressure source may be housed within or used in conjunction with other components, such as sensors, processing units, alarm indicators, memory, databases, software, display devices, or operator interfaces that further facilitate negative-pressure therapy.
- the pressure is generally a low vacuum, also commonly referred to as a rough vacuum between ⁇ 5 mm Hg ( ⁇ 667 Pa) and ⁇ 500 mm Hg ( ⁇ 66.7 kPa).
- Common therapeutic ranges are between ⁇ 75 mm Hg ( ⁇ 9.9 kPa) and ⁇ 300 mm Hg ( ⁇ 39.9 kPa).
- the tissue interface 110 can be generally adapted to contact a tissue site.
- the tissue interface 110 may be partially or fully in contact with the tissue site. If the tissue site is a wound, for example, the tissue interface 110 may partially or completely fill the wound, or may be placed over the wound.
- the tissue interface 110 may take many forms, and may have many sizes, shapes, or thicknesses depending on a variety of factors, such as the type of treatment being implemented or the nature and size of a tissue site. For example, the size and shape of the tissue interface 110 may be adapted to the contours of deep and irregular shaped tissue sites.
- the tissue interface 110 may be a manifold.
- a “manifold” in this context generally includes any substance or structure providing a plurality of pathways adapted to collect or distribute fluid across a tissue site under negative pressure.
- a manifold may be adapted to receive negative pressure from a source and distribute the negative pressure through multiple apertures across a tissue site, which may have the effect of collecting fluid from across a tissue site and drawing the fluid toward the source.
- the fluid path may be reversed or a secondary fluid path may be provided to facilitate delivering fluid across a tissue site.
- the pathways of a manifold may be channels interconnected to improve distribution or collection of fluids across a tissue site.
- cellular foam, open-cell foam, reticulated foam, porous tissue collections, and other porous material such as gauze or felted mat generally include pores, edges, and/or walls adapted to form interconnected fluid pathways.
- Liquids, gels, and other foams may also include or be cured to include apertures and flow channels.
- a manifold may be a porous foam material having interconnected cells or pores adapted to distribute negative pressure across a tissue site.
- the foam material may be either hydrophobic or hydrophilic.
- a manifold may be an open-cell, reticulated polyurethane foam such as GranuFoam® dressing available from Kinetic Concepts, Inc. of San Antonio, Tex.
- the tissue interface 110 may be made from a hydrophilic material
- the tissue interface 110 may also wick fluid away from a tissue site, while continuing to distribute negative pressure to the tissue site.
- the wicking properties of the tissue interface 110 may draw fluid away from a tissue site by capillary flow or other wicking mechanisms.
- An example of a hydrophilic foam is a polyvinyl alcohol, open-cell foam such as V.A.C. WhiteFoam® dressing available from Kinetic Concepts, Inc. of San Antonio, Tex.
- Other hydrophilic foams may include those made from polyether.
- Other foams that may exhibit hydrophilic characteristics include hydrophobic foams that have been treated or coated to provide hydrophilicity.
- the tissue interface 110 may further promote granulation at a tissue site when pressure within the sealed therapeutic environment 118 is reduced.
- any or all of the surfaces of the tissue interface 110 may have an uneven, coarse, or jagged profile that can induce microstrains and stresses at a tissue site if negative pressure is applied through the tissue interface 110 .
- the tissue interface 110 may be constructed from bioresorbable materials. Suitable bioresorbable materials may include, without limitation, a polymeric blend of polylactic acid (PLA) and polyglycolic acid (PGA). The polymeric blend may also include without limitation polycarbonates, polyfumarates, and capralactones.
- the tissue interface 110 may further serve as a scaffold for new cell-growth, or a scaffold material may be used in conjunction with the tissue interface 110 to promote cell-growth.
- a scaffold is generally a substance or structure used to enhance or promote the growth of cells or formation of tissue, such as a three-dimensional porous structure that provides a template for cell growth.
- Illustrative examples of scaffold materials include calcium phosphate, collagen, PLA/PGA, coral hydroxy apatites, carbonates, or processed allograft materials.
- the drape 108 is an example of a sealing member.
- a sealing member may be constructed from a material that can provide a fluid seal between two environments or components, such as between a therapeutic environment and a local external environment.
- a sealing member may be, for example, an impermeable or semi-permeable, elastomeric film or barrier that can provide a seal adequate to maintain a negative pressure at a tissue site for a given negative-pressure source.
- the permeability generally should be low enough that a desired negative pressure may be maintained.
- a drape suitable for covering a tissue site for negative-pressure therapy may comprise a film having a thickness between about 25 microns and about 50 microns that is water-vapor permeable and formed of a polymer.
- the film may be coated with an adhesive having a coating weight between about 25 gsm and about 65 gsm.
- the adhesive may often be acrylic-based and pressure sensitive.
- a pressure-sensitive adhesive increases in bond strength when pressed against the surface to which the adhesive is being bonded.
- a pressure-sensitive adhesive may undergo a physical change when compressed against a surface.
- a pressure-sensitive adhesive may flow into crevices of a surface when compressed, increasing the bond strength without undergoing a physical change.
- An attachment device may be used to attach a sealing member to an attachment surface, such as undamaged epidermis, a gasket, or another sealing member.
- the attachment device may take many forms.
- an attachment device may be a medically-acceptable, pressure-sensitive adhesive that extends about a periphery, a portion, or an entire sealing member.
- the attachment device may be an acrylic-based pressure sensitive adhesive having a coating weight between about 25 grams/m 2 (gsm) and about 60 gsm.
- Other example embodiments of an attachment device may include a double-sided tape, paste, hydrocolloid, hydrogel, silicone gel, organogel, or an acrylic adhesive.
- a “container” broadly includes a canister, pouch, bottle, vial, or other fluid collection apparatus.
- a container for example, can be used to manage exudates and other fluids withdrawn from a tissue site.
- a rigid container may be preferred or required for collecting, storing, and disposing of fluids.
- fluids may be properly disposed of without rigid container storage, and a re-usable container could reduce waste and costs associated with negative-pressure therapy.
- a connector 114 may be used to fluidly couple the tube 112 to the sealed therapeutic environment 118 .
- the negative pressure developed by the negative-pressure source 106 may be delivered through the tube 112 to the connector 114 .
- the connector 114 may be a T.R.A.C.® Pad or Sensa T.R.A.C.® Pad available from KCI of San Antonio, Tex.
- the connector 114 allows the negative pressure to be delivered to the sealed therapeutic environment 118 .
- the connector 114 may also be a tube inserted through the drape 108 .
- the negative pressure may also be generated by a device directly coupled to the drape 108 , such as a micropump.
- negative-pressure therapy with negative-pressure therapy systems is increasingly being performed with smaller therapy devices that use battery power rather than a connection to an electrical outlet.
- Use of battery power decreases the total power supply available to a therapy device.
- power drains that would be considered negligible in a device powered through an electrical outlet connection may significantly reduce the ability of the therapy device to provide therapy.
- a power drain refers to operation of the therapy device that requires use of electrical power, for example, operation of a pump to generate negative pressure.
- Power drains may be caused by low-level dressing leaks, for example.
- a low-level dressing leak can drain power from a battery of a therapy device by repeatedly triggering operation of the therapy device to maintain the necessary negative pressure at the tissue site.
- Leak detection techniques may help to identify some leaks that may be sealed by the user; however, low-level leaks will challenge the most sensitive leak detection systems and may often go undetected.
- Low-level dressing leaks may occur between a drape and epidermis surrounding a tissue site if the drape fails to completely seal to the epidermis.
- a drape may include an adhesive having a strength sufficient to seal against leaks but that may also cause pain to a patient if the drape is removed.
- a drape using an acrylic adhesive as described above is generally suitable for a dressing if a negative-pressure source powered by a continuous power supply can compensate for a leak.
- a bonding adhesive may have a bond strength that is greater than the bond strength of the standard acrylic adhesive.
- a bonding adhesive may be better for sealing than a standard acrylic adhesive, but the bond strength would cause significantly more discomfort if the drape is removed.
- removing a drape having a bonding adhesive may cause significant damage to patients having delicate or damaged skin.
- a drape that has a sealing adhesive can fill gaps between the drape and the epidermis to limit leaks and can be easy to remove with low discomfort to the patient.
- Various sealing, gap-filling adhesives such as silicone, hydrocolloids, and hydrogels, have been tried but each has drawbacks.
- hydrogel adhesives are usually low tack and prone to swelling, creep, and mobility when used with fluid systems. Available hydrogels and hydrocolloids do not adhere well and may move when anchored.
- silicone adhesives can fill gaps and seal, but are not breathable and may lose the necessary mechanical bonding strength as the silicone adhesives interact with moisture during use.
- a hybrid drape having a thick sealing layer that is perforated and laminated over an adhesive coated film can overcome many of these challenges.
- a hybrid drape may include a film layer having a bonding adhesive applied directly to the film layer, and a sealing adhesive applied directly to the bonding adhesive.
- the sealing adhesive can be perforated to expose the bonding adhesive.
- the bonding adhesive can be pushed through the perforations of the sealing adhesive to secure the sealing adhesive to the patient.
- This laminated configuration may provide the benefits of the sealing adhesive and the bonding adhesive over the entire drape area.
- the laminated configuration can seal typical low-level leaks and mechanically affix to the epidermis without secondary processes.
- the laminated configuration may also require minimal additional application care by the user and can be removable with minimal trauma to the patient.
- construction of the laminated configuration requires additional assembly steps and an increase in materials that may significantly increase costs.
- hybrid drapes may register a bonding adhesive and a sealing adhesive. These hybrid drapes apply both the bonding adhesive and the sealing adhesive directly to a film layer.
- the bonding adhesive and the sealing adhesive may each cover different portions of the film layer to reduce the overall thickness of the hybrid drape and decrease the amount of adhesive needed to construct the hybrid drape.
- the complexity of the manufacturing process may also have increased costs relative to a non-hybrid drape.
- a standard drape having a standard acrylic adhesive may be used while treatment occurs in a care facility, such as a hospital.
- the negative-pressure therapy may be performed using a wall-powered negative-pressure source.
- a patient may be discharged from a care facility before negative-pressure therapy concludes.
- Negative-pressure therapy may continue outside of the care facility using a portable negative-pressure source.
- a hybrid drape may be applied to address leaking issues that may arise with a portable negative-pressure source.
- the negative-pressure therapy system 100 can overcome these challenges and others by providing the sealing tape 124 having a hybrid adhesive configuration.
- the sealing tape 124 may have two adhesives, a bonding adhesive and a sealing adhesive. As shown in FIG. 1A , the sealing tape 124 may be applied to the drape 108 so that the sealing tape 124 may partially couple to the drape 108 and partially couple to the epidermis 116 , covering an edge of the drape 108 . The sealing tape 124 may provide increased sealing of the drape 108 to the epidermis 116 .
- FIG. 1B is a plan view of the dressing 104 illustrating additional details that may be associated with some embodiments.
- the tissue interface 110 may be disposed at the tissue site 102 and covered with the drape 108 to form the sealed therapeutic environment 118 .
- the sealing tape 124 may be positioned to cover edges of the drape 108 .
- the sealing tape 124 may be partially coupled to the drape 108 and partially coupled to the epidermis 116 .
- ends of the sealing tape 124 may overlap one another.
- FIG. 2A is a sectional view of the negative-pressure therapy system 100 for treating the tissue site 102 with negative pressure illustrating details that may be associated another embodiment.
- the sealing tape 124 may be applied directly to the epidermis 116 adjacent to the tissue site 102 .
- the drape 108 may be coupled directly to the sealing tape 124 .
- the sealing tape 124 may provide a stronger bond to the epidermis 116 and a better surface for the drape 108 to seal to, decreasing the size of the leaks through the dressing 104 .
- the drape 108 may bond directly to a surface of the sealing tape 124 opposite the epidermis 116 .
- the surface of the sealing tape 124 may be formed of a material to which the standard adhesive of the drape 108 may bond to more readily than the epidermis 116 .
- the surface of the drapes strips 124 may have fewer crevices, bumps, and cracks than the epidermis 116 , providing a better bonding surface for the drape 108 .
- FIG. 2B is a plan view of the dressing 104 illustrating additional details that may be associated with some embodiments.
- the tissue interface 110 may be disposed at the tissue site 102 .
- the sealing tape 124 may be disposed around the tissue site 102 to form a window 125 , the tissue site 102 being within boundaries of the window 125 .
- the window 125 may be an area of tissue having peripheral portions bounded by the sealing tape 124 .
- four sealing tape 124 may be disposed on the epidermis 116 so that the window 125 has a square shape having the tissue site 102 within the window 125 . In other embodiments, more or fewer sealing tape 124 may be used as needed and may form other shapes.
- the sealing tape 124 may couple directly to the epidermis 116 .
- the drape 108 may then be coupled at least to the sealing tape 124 to cover the tissue site 102 and the tissue interface 110 to form the sealed therapeutic environment 118 .
- ends of the sealing tape 124 may overlap.
- the sealing tape 124 may be cut so that ends of the sealing tape 124 do not overlap.
- FIG. 3 is an exploded perspective view of the sealing tape 124 , illustrating details that may be associated with some embodiments.
- the sealing tape 124 may include a film layer 126 , a layer of a bonding adhesive 128 , and a layer of a sealing adhesive 130 .
- the film layer 126 may be liquid-impermeable and vapor-permeable, that is, the film layer 126 may allow vapor to egress and inhibit liquids from exiting.
- the film layer 126 may be a flexible film that is breathable and may have a high moisture vapor transfer rate (MVTR), for example, greater than or equal to about 300 g/m 2 /24 hours.
- MVTR moisture vapor transfer rate
- the film layer 126 may be formed from a range of medically approved films ranging in thickness typically from about 15 microns ( ⁇ m) to about 50 microns ( ⁇ m). In other embodiments, a drape having a low MVTR or that allows no vapor transfer might be used. In some embodiments, the film layer 126 can also function as a barrier to liquids and microorganisms.
- the film layer 126 may be formed from numerous materials, such as one or more of the following: hydrophilic polyurethane (PU), cellulosics, hydrophilic polyamides, polyvinyl alcohol, polyvinyl pyrrolidone, hydrophilic acrylics, hydrophilic silicone elastomers, and copolymers of these.
- the film layer 126 may be formed from a breathable cast matt polyurethane film sold by Expopack Advanced Coatings of Wrexham, United Kingdom, under the name INSPIRE 2301 .
- the illustrative film may have an MVTR (inverted cup technique) of 14400 g/m 2 /24 hours and may be approximately 30 microns thick.
- the bonding adhesive 128 may be coupled directly to the film layer 126 .
- the bonding adhesive 128 and the film layer 126 may be coextensive. In other embodiments, the bonding adhesive 128 and the film layer 126 may not be coextensive.
- a bonding adhesive may be a medically-acceptable, pressure-sensitive adhesive.
- a bonding adhesive may be formed from an acrylic adhesive, rubber adhesive, high-tack silicone adhesive, polyurethane, or other substance.
- a bonding adhesive may be formed from an acrylic adhesive with a coating weight of about 15 gsm to about 70 gsm.
- a bonding adhesive may also be a high-bond strength acrylic adhesive, patterrubber adhesive, high-tack silicone adhesive, or polyurethane, for example.
- the bond strength or tackiness of a bonding adhesive may have a peel adhesion or resistance to being peeled from a stainless steel material between about 6 Newtons/25 millimeters (N/mm) to about 10N/25 mm on stainless steel substrate at 23° C. at 50% relative humidity based on the American Society for Testing and Materials (“ASTM”) standard ASTM D3330.
- the bonding adhesive 128 may be a continuous layer of material or may be a layer with apertures (not shown).
- the apertures may be formed after application of the bonding adhesive 128 or may be formed by coating the bonding adhesive 128 in patterns on a carrier layer.
- the apertures may be sized to help control the resultant tackiness of the bonding adhesive 128 .
- the apertures may also be sized to enhance the MVTR of the sealing tape 124 .
- the bonding adhesive 128 may couple the film layer 126 to the sealing adhesive 130 .
- the sealing adhesive 130 has a thickness 132 that may be in the range of about 100 microns ( ⁇ m) to about 1000 microns ( ⁇ m).
- a sealing adhesive may be a soft material that provides a good seal with the tissue site 102 .
- a sealing adhesive may be formed of a silicone gel (or soft silicone), hydrocolloid, hydrogel, polyurethane gel, polyolefin gel, hydrogenated styrenic copolymer gels, or foamed gels with compositions as listed, or soft closed cell foams (polyurethanes, polyolefins) coated with an adhesive (e.g., 30 gsm-70 gsm acrylic), polyurethane, polyolefin, or hydrogenated styrenic copolymers.
- an adhesive e.g., 30 gsm-70 gsm acrylic
- a sealing adhesive may have a stiffness between about 5 Shore 00 and about 80 Shore 00.
- a sealing adhesive may be hydrophobic or hydrophilic.
- a sealing adhesive may be an adhesive having a low to medium tackiness, for example, a silicone polymer, polyurethane, or an additional acrylic adhesive.
- the bond strength or tackiness of a sealing adhesive may have a peel adhesion or resistance to being peeled from a stainless steel material between about 0.5N/25 mm to about 1.5N/25 mm on stainless steel substrate at 23° C. at 50% relative humidity based on ASTM D3330.
- a sealing adhesive may achieve the bond strength above after a contact time of less than 60 seconds.
- Tackiness may be considered a bond strength of an adhesive after a very low contact time between the adhesive and a substrate.
- a sealing adhesive may have a tackiness that may be about 30% to about 50% of the tackiness of a bonding adhesive.
- the sealing adhesive 130 may be formed with a plurality of apertures 134 .
- the apertures 134 may be numerous shapes, for example, circles, squares, stars, ovals, polygons, slits, complex curves, rectilinear shapes, triangles, or other shapes.
- Each aperture 134 of the plurality of apertures 134 may have an effective diameter.
- An effective diameter may be a diameter of a circular area having the same surface area as the aperture 134 .
- the average effective diameter of each aperture 134 may be in the range of about 6 mm to about 50 mm.
- the apertures 134 may have a uniform pattern or may be randomly distributed on the sealing adhesive 130 .
- the apertures 134 may be distributed so that the apertures 134 extend to edges of the sealing tape 124 . In other embodiments, the apertures 134 may be distributed so that a portion of the sealing adhesive 130 includes no apertures 134 .
- FIG. 4A is a sectional view of a portion of the sealing tape 124 illustrating additional details that may be associated with some embodiments.
- the bonding adhesive 128 may be coupled to the film layer 126
- the sealing adhesive 130 may be coupled to the bonding adhesive 128 . If the sealing adhesive 130 is placed proximate to or in contact with the epidermis 116 , the sealing adhesive 130 may form sealing couplings 131 with the epidermis 116 . In some embodiments, the thickness 132 of the sealing adhesive 130 may create a gap 133 between the bonding adhesive 128 and the epidermis 116 .
- FIG. 4B is a sectional view of the sealing tape 124 illustrating additional details that may be associated with some embodiments. If the sealing tape 124 is in a desired location, pressure may be applied to the film layer 126 . The pressure may cause the bonding adhesive 128 to be pressed at least partially into contact with the epidermis 116 to form bonding couplings 136 . The bonding couplings 136 may provide secure, releasable mechanical fixation to the epidermis 116 . The sealing couplings 131 between the sealing adhesive 130 and the epidermis 116 may be sufficient to seal the film layer 126 to the epidermis 116 .
- the sealing couplings 131 may not be as mechanically strong as the bonding couplings 136 between the bonding adhesive 128 and the epidermis 116 .
- the bonding couplings 136 may also anchor the sealing tape 124 to the epidermis 116 , inhibiting migration of the sealing tape 124 and the sealing adhesive 130 .
- the average effective diameter of the apertures 134 of the sealing adhesive 130 may be varied as one control of the tackiness or adhesion strength of the sealing tape 124 .
- the more bonding adhesive 128 that extends through the apertures 134 the stronger the bond of the bonding coupling 136 .
- the smaller the thickness 132 of the sealing adhesive 130 the more bonding adhesive 128 generally extends through the apertures 134 and the greater the bond of the bonding coupling 136 .
- the average effective diameter of the plurality of apertures 134 may be relatively smaller.
- the thickness 132 may be approximately 200 microns
- the bonding adhesive 128 may be approximately 30 microns
- the average effective diameter may be about 6 mm.
- FIG. 5 is an exploded perspective view of the sealing tape 124 illustrating additional details that may be associated with some embodiments.
- the sealing tape 124 may include the film layer 126 and an adhesive layer 138 adjacent to the film layer 126 .
- FIG. 6 is an exploded cross sectional view of the sealing tape 124 illustrating additional details that may be associated with some embodiments.
- the film layer 126 may have a first side 140 and a second side 142 .
- the adhesive layer 138 may be coupled to the second side 142 of the film layer 126 .
- the adhesive layer 138 may be a medically-acceptable, pressure-sensitive adhesive, glue, bonding agent, or cement, for example. In some embodiments, two adhesives having different characteristics may be used to form the adhesive layer 138 .
- the adhesive layer 138 may include a first adhesive such as the bonding adhesive 128 and a second adhesive such as the sealing adhesive 130 .
- the placement of the bonding adhesive 128 and the sealing adhesive 130 may be coordinated so that the bonding adhesive 128 and the sealing adhesive 130 both couple directly to the second side 142 of the film layer 126 .
- the bonding adhesive 128 may be disposed on the film layer 126 in a pattern and may be about 30 microns to about 60 microns in thickness.
- the bonding adhesive 128 of the adhesive layer 138 comprises an acrylic adhesive with coating weight of 15 grams/m 2 (gsm) to 70 grams/m 2 (gsm).
- the sealing adhesive 130 may be disposed on the film layer 126 in a pattern and may be about 100 microns to about 400 microns thick.
- the adhesive layer 138 may partially cover the second side 142 of the film layer 126 , leaving portions of the second side 142 of the film layer 126 free of adhesive.
- the adhesive layer 138 may be coextensive with the second side 142 of the film layer 126 .
- FIG. 7 is a sectional view of the sealing tape 124 illustrating additional details that may be associated with some embodiments.
- the thickness of the bonding adhesive 128 may be less than the thickness of the sealing adhesive 130 so that the adhesive layer 138 may have a varying thickness. If the adhesive layer 138 is applied to the epidermis 116 , the sealing adhesive 130 may can form the sealing couplings 131 with the epidermis 116 . In some embodiments, the thickness of the bonding adhesive 128 may be less than the thickness of the sealing adhesive 130 , forming the gap 133 between the bonding adhesive 128 and the epidermis 116 .
- FIG. 8 is a sectional view of the sealing tape 124 illustrating additional details that may be associated with some embodiments. If the sealing tape 124 is in a desired location, pressure may be applied to the first side 140 of the film layer 126 . The pressure may cause the bonding adhesive 128 to be pressed at least partially into contact with the epidermis 116 to form the bonding couplings 136 . The bonding couplings 136 can provide secure, releasable mechanical fixation to the epidermis 116 . The sealing couplings 131 between the sealing adhesive 130 and the epidermis 116 may be sufficient to seal the film layer 126 to the epidermis 116 . The sealing couplings 131 may not be as mechanically strong as the bonding couplings 136 between the bonding adhesive 128 and the epidermis 116 .
- the tissue interface 110 may be disposed proximate to the tissue site 102 .
- the drape 108 may be disposed over the tissue interface 110 and the epidermis 116 to form the sealed therapeutic environment 118 .
- the sealing tape 124 may be applied to the edge of the drape 108 so that a width of each sealing tape 124 overlaps an edge of the drape 108 .
- each sealing tape 124 may partially cover the drape 108 and partially cover the epidermis 116 .
- the bonding adhesive 128 of the sealing tape 124 may form bonding couplings 136 with the epidermis 116 and a top surface of the drape 108 , while the sealing adhesive 130 may form sealing couplings 131 with the epidermis 116 and the top surface of the drape 108 .
- the bonding couplings 136 may have a peel force against the epidermis 116 between about 0.5N/25 mm to about 2N/25 mm. In this manner, the sealing tape 124 may seal the edges of the drape 108 , decreasing leaks between the drape 108 and the epidermis 116 .
- the tissue interface 110 may be disposed proximate to the tissue site 102 .
- One or more sealing tape 124 may be disposed around the tissue site 102 to form the window 125 containing the tissue site 102 .
- the sealing adhesive 130 of each sealing tape 124 may form the sealing couplings 131 with the epidermis 116
- the bonding adhesive 128 of each sealing tape 124 may form the bonding couplings 136 with the epidermis 116 .
- the bonding couplings 136 may have a peel force against the epidermis 116 between about 0.5N/25 mm to about 2N/25 mm.
- the drape 108 may be disposed over the tissue interface 110 and the epidermis 116 and coupled to the sealing tape 124 to form the sealed therapeutic environment 118 .
- the bonding couplings 136 and the sealing couplings 136 of the sealing tape 124 may seal the sealing tape 124 to the epidermis 116 .
- the drape 108 may be coupled to the film layer 126 of the sealing tape 124 .
- the first surface 140 of the film layer 126 may provide a bonding surface that is more suitable for adhesion by the standard adhesive of the drape 108 than the epidermis 116 . In this manner, the sealing tape 124 may decrease instances of leaks between the drape 108 and the epidermis 116 .
- the pattern of the bonding adhesive 128 and the pattern of the sealing adhesive 130 may be registered.
- Registration of the bonding adhesive 128 and the sealing adhesive 130 generally refers to the alignment of the two adhesives relative to one another.
- registration of the bonding adhesive 128 and the sealing adhesive 130 may refer to the coordination of adhesive placement on the film layer 126 to achieve a desired effect. For example, a certain percentage of overlap of one adhesive over the other adhesive, minimal overlap of one adhesive over the other adhesive so that the adhesives are offset from one another, or complete overlap of one adhesive over the other adhesive are all adhesive placements that may be considered registered.
- the bonding adhesive 128 and the sealing adhesive 130 may be registered by being disposed on the second side 142 of the film layer 126 so that the bonding adhesive 128 and the sealing adhesive 130 each substantially couple to the second side 142 of the film layer 126 .
- the bonding adhesive 128 and the sealing adhesive 130 of the example may be aligned relative to one another to have minimal overlap of one adhesive over the other adhesive.
- the sealing adhesive 130 may be offset from the bonding adhesive 128 , with both adhesives being coupled to the second side 142 of the film layer 126 . Registering the bonding adhesive 128 and the sealing adhesive 130 can provide for easier manufacturing and use of the sealing tape 124 .
- Registering of the bonding adhesive 128 and the sealing adhesive 130 may also enhance desired properties of the sealing tape 124 as described in more detail below. Illustrative, but non-limiting, examples of the registration of the bonding adhesive 128 and the sealing adhesive 130 may be described in more detail with respect to the following embodiments.
- FIG. 9 is a plan view of the sealing tape 124 illustrating additional details that may be associated with some embodiments.
- the sealing tape 124 may have a width 160 and a length 162 .
- the width 160 may be between about 20 mm.
- the width 160 may be between about 10 mm to about 30 mm.
- the length 162 may be up to about 200 mm.
- the sealing tape 124 may be cut or torn so that a sealing tape 124 having the length 162 suitable for use may be provided.
- a sealing tape 124 may be provided in rolls, allowing a clinician to select a length suitable for a particular tissue site and cut or tear an end of the sealing tape 124 to remove it from the roll.
- the sealing tape 124 may also include the bonding adhesive 128 and the sealing adhesive 130 having apertures 134 .
- the bonding adhesive 128 may have a coating weight of about 25 gsm.
- the sealing adhesive 130 may have a coating weight of about 100 gsm to about 600 gsm.
- the apertures 134 may have a diameter between about 7 mm to about 10 mm. In other embodiments, the apertures 134 may have a diameter between about 5 mm to about 30 mm.
- the sealing tape 124 may include two rows of apertures 134 that may be offset from one another. In some embodiments, the apertures 134 may be evenly distributed on the sealing tape 124 .
- FIG. 10 is a plan view of a sealing tape 224 illustrating additional details that may be associated with some embodiments.
- the sealing tape 224 may be similar to and operate in a manner similar to the sealing tape 124 of FIG. 9 . Similar elements have been indexed to 200 .
- the sealing tape 224 may have a width 260 , a length 262 , a layer of a bonding adhesive 228 , a layer of a sealing adhesive 230 , and apertures 234 .
- the apertures 234 may be positioned similar to the apertures 134 .
- the sealing adhesive 230 of the sealing tape 224 may include edge apertures 235 .
- the edge apertures 235 may be semi-circles having a radius equal to a radius of the apertures 234 .
- the edge apertures 235 may be positioned so that a diameter of each edge aperture 235 is adjacent to an edge of the sealing tape 224 that is parallel to the length 262 .
- the edge apertures 235 may be disposed along both edges. In other embodiments, the edge apertures 235 may only be disposed along one edge.
- the apertures 234 and the edge apertures 235 may be evenly distributed on the sealing tape 224 . For example, each aperture 234 and edge aperture 235 may be separated from adjacent apertures 234 and edge apertures 235 by a same distance.
- an even distribution may produce a sealing tape 224 having apertures 234 and apertures 235 extending between edges of the sealing tape 224 at regularly repeating distances.
- the apertures 235 may expose a portion of the bonding adhesive 228 at the edges of the sealing tape 224 . Exposure of the bonding adhesive 228 proximate to the edge of the sealing tape 224 may aid in resistance to edge lifting during use of the sealing tape 224 . Edge lifting may be the lifting of a portion of the sealing tape 224 when the edge of the sealing tape 224 is caught by clothing or other objects.
- FIG. 11 is a plan view of a sealing tape 324 illustrating additional details that may be associated with some embodiments.
- the sealing tape 324 may be similar to and operate in a manner similar to the sealing tape 124 of FIG. 9 . Similar elements have been indexed to 300 .
- the sealing tape 324 may have a width 360 , a length 362 , a layer of a bonding adhesive 328 , a layer of a sealing adhesive 330 , and apertures 334 .
- the apertures 134 may have a diameter between about 10 mm and about 15 mm. In other embodiments, the apertures 334 may have a diameter between about 5 mm and about 30 mm.
- the sealing tape 324 may include a single row of apertures 334 .
- the apertures are disposed near a center of the width 360 of the sealing tape 334 and may be evenly distributed parallel to the length 362 of the sealing tape 334 .
- FIG. 12 is a plan view of a sealing tape 424 illustrating additional details that may be associated with some embodiments.
- the sealing tape 424 may be similar to and operate in a manner similar to the sealing tape 224 of FIG. 10 . Similar elements have been indexed to 400 .
- the sealing tape 424 may have a width 460 , a length 462 , a layer of a bonding adhesive 428 , a layer of a sealing adhesive 430 , and apertures 435 .
- the apertures 435 may be positioned similar to the apertures 235 and have a radius equal to a radius of the apertures 334 .
- FIG. 13 is a plan view of a sealing tape 524 illustrating additional details that may be associated with some embodiments.
- the sealing tape 524 may be similar to and operate in a manner similar to the sealing tape 124 of FIG. 9 . Similar elements have been indexed to 500 .
- the sealing tape 524 may have a width 560 , a length 562 , a strip of a bonding adhesive 528 , and a strip of a sealing adhesive 530 .
- the sealing tape 524 may include two strips of the sealing adhesive 530 disposed adjacent to an edge of the sealing tape 524 . The two strips of the sealing adhesive 530 may be parallel to the length 562 .
- the two strips of the sealing adhesive 530 may each have a width 564 .
- the width 564 of each strip of the sealing adhesive 530 may be between about 5 mm and about 7 mm.
- a width 566 of the bonding adhesive 528 exposed through the sealing adhesive 530 may be between about 6 mm and about 10 mm.
- FIG. 14 is a plan view of a sealing tape 624 illustrating additional details that may be associated with some embodiments.
- the sealing tape 624 may be similar to and operate in a manner similar to the sealing tape 524 of FIG. 13 . Similar elements have been indexed to 600 .
- the sealing tape 624 may have a width 660 , a length 662 , one or more strips of a bonding adhesive 628 , and one or more strips of a sealing adhesive 630 .
- the sealing tape 624 may include two strips of the sealing adhesive 630 .
- a first strip 631 of the sealing adhesive 630 may be disposed adjacent to an edge of the sealing tape 624 .
- a second strip 633 of the sealing adhesive 630 may be disposed between the edges of the sealing tape 624 .
- the first strip 631 and the second strip 633 of the sealing adhesive 630 may be parallel to the length 662 .
- the first strip 631 and the second strip 633 of the sealing adhesive 630 may each have a width 664 .
- the width 664 may be between about 5 mm and about 7 mm.
- the portion of the bonding adhesive 628 exposed through the sealing adhesive 630 may include a first strip 627 and a second strip 629 .
- the first strip 627 may be disposed between the first strip 631 and the second strip 633 of the sealing adhesive 630 .
- the second strip 629 may be disposed adjacent to an edge of the sealing tape 624 opposite the first strip 631 .
- a width 666 of each of the first strip 627 and the second strip 629 of the bonding adhesive 628 exposed through the sealing adhesive 630 may be between about 3 mm and about 5 mm.
- the sealing tape 624 may be applied so that the second strip 629 of the bonding adhesive 628 may be in contact with the epidermis 116 to form bonding couplings 136 with the epidermis.
- the first strip 627 of the bonding adhesive 628 may be in contact with the drape 108 to form bonding couplings 136 with the drape 108 .
- FIG. 15 is a plan view of a sealing tape 724 illustrating additional details that may be associated with some embodiments.
- the sealing tape 724 may be similar to and operate in a manner similar to the sealing tape 124 of FIG. 9 . Similar elements have been indexed to 700 .
- the sealing tape 724 may have a width 760 , a length 762 , a bonding adhesive 728 , and a sealing adhesive 730 .
- the sealing adhesive 730 may trace a path between opposite edges of the sealing tape 724 .
- the sealing adhesive 730 may propagate parallel to the length 762 .
- the sealing adhesive 730 may have a pattern similar to a wave.
- the sealing adhesive 730 may have a regular wave pattern with a repeating slope between each edge of the sealing tape 724 . In some embodiments, the sealing adhesive 730 may have a width 768 . In some embodiments, the width 768 may be between about 5 mm and about 7 mm.
- Any of the above patterns may be manufacturing by layering the adhesives as described above with respect to FIG. 3 , FIG. 4A , and FIG. 4B or by registering the adhesives as described above with respect to FIG. 5 , FIG. 6 , FIG. 7 , and FIG. 8 .
- the adhesives may be mixed with blowing or expanding agents, for example organic and inorganic low temperature boiling point liquids.
- the blowing or expanding agents allow for the adhesives to expand under the application of heat or light to increase the thickness of the adhesive following deposition by one of the above described processes.
- the blowing or expanding agents may reduce the amount of adhesive needed and decrease the cost of production and the cost of the resulting sealing tape 124 .
- the application of heat or light may be delayed until application of the sealing tape 124 to the epidermis 116 so that the contact area with the patient's epidermis 116 may increase as the bonding adhesive 128 and the sealing adhesive 130 warm by contact with the patient's epidermis 116 .
- the application of light or heat following application of the sealing tape 124 to the epidermis 116 can provide a better seal for some embodiments of the sealing tape 124 to the epidermis 116 .
- leaks between a standard drape and a textured surface were reduced.
- a drape was disposed over the textured surface to create a sealed space.
- the drape was fluidly coupled to a negative-pressure source.
- the negative-pressure source was operated and a pressure was measured in the sealed space. When the pressure was measured, the negative-pressure source was unable to achieve 125 mm Hg negative pressure.
- a leak of about 2 L/m was determined to exist between the standard drape and the textured surface.
- Sealing tape in accordance with the embodiments described herein were applied to the edges of the drape.
- the negative-pressure source was again operated and the pressure measured in the sealed space.
- the negative-pressure source was able to achieve the therapy pressure of 125 mm Hg and the leak was reduced to 0.08 L/m.
- the textured surface was then heated, further reducing the leak to 0.01 L/m.
- Sealing tape in accordance with the embodiments described herein were also disposed directly on the texture surface.
- the standard drape was disposed over the textured surface and coupled to the sealing tape to create the sealed space.
- the textured surface was heated to mimic a patient's body heat.
- the standard drape was fluidly coupled to the negative-pressure source.
- the negative-pressure source was operated and a pressure was measured in the sealed space.
- the negative-pressure source was able to achieve 125 mm Hg negative pressure and the leak was reduced to 0.003 L/m.
- the sealing tape may provide a lower cost solution to improving the sealing of standard drapes.
- the sealing tape may be added to current dressings with low disruption to production or use.
- the sealing tape also provide a step-change improvement in sealing with a pre-applied dressing using existing materials prior to release from a facility.
- the sealing tape may also later be used under a drape on re-application of the dressing to provide a seal to a tissue site.
- the sealing tape may also provide an increased efficiency of adhesive usage as less silicone adhesive may be needed to retain the silicone adhesive in place and under compression with the acrylic adhesive.
Abstract
Description
- This application is a divisional of U.S. patent application Ser. No. 14/517,521, filed Oct. 17, 2014, entitled “HYBRID SEALING TAPE” which claims the benefit, under 35 USC § 119(e), of the filing of U.S. Provisional Patent Application Ser. No. 61/896,582, entitled “HYBRID DRAPE STRIPS,” filed Oct. 28, 2013, which is incorporated herein by reference for all purposes.
- The present disclosure relates generally to dressings for adhering to a patient, and more particularly, but without limitation, to a hybrid sealing tape having at least two adhesives disposed thereon.
- Clinical studies and practice have shown that reducing pressure in proximity to a tissue site can augment and accelerate growth of new tissue at the tissue site. The applications of this phenomenon are numerous, but it has proven particularly advantageous for treating wounds. Regardless of the etiology of a wound, whether trauma, surgery, or another cause, proper care of the wound is important to the outcome. Treatment of wounds with negative pressure is commonly referred to as “negative-pressure therapy,” but may also be known by other names, including “negative pressure wound therapy,” “reduced-pressure therapy,” and “vacuum therapy,” for example. Negative-pressure therapy may provide a number of benefits, including migration of epithelial and subcutaneous tissues, improved blood flow, and micro-deformation of tissue at a wound site. Together, these benefits can increase development of granulation tissue and reduce healing times.
- While the clinical benefits of negative-pressure therapy are widely known, the cost and complexity of negative-pressure therapy can be a limiting factor in its application, and the development and operation of negative-pressure systems, components, and processes continues to present significant challenges to manufacturers, healthcare providers, and patients.
- According to an illustrative, non-limiting embodiment, a dressing for treating a tissue site with negative pressure is described. The dressing may include a tissue interface configured to be positioned adjacent to the tissue site. The dressing also may include a sealing member configured to be positioned over the tissue interface and the tissue site to form a sealed environment. The dressing further may include one or more sealing tape configured to be coupled to the sealing member and epidermis adjacent to the tissue site. The sealing tape each may have a bonding adhesive and a sealing adhesive coupled to a side of each sealing tape.
- According to another illustrative embodiment, a system for treating a tissue site with negative-pressure is described. The system may include a manifold configured to be positioned adjacent to the tissue site and a drape configured to be positioned over the tissue site and the manifold and configured to seal to tissue adjacent to the tissue site to form a sealed space. The system also may include a negative-pressure source configured to provide negative-pressure to the sealed space. The system further may include one or more sealing tape configured to be coupled to the drape and epidermis adjacent to the tissue site. The sealing tape may each have a bonding adhesive and a sealing adhesive coupled to a side of each sealing tape.
- According to another illustrative embodiment, a method for treating a tissue site with negative-pressure is described. A manifold may be disposed adjacent to the tissue site. The manifold may be covered with a drape and the drape may be sealed to tissue adjacent to the tissue site to form a sealed space. A negative-pressure source may be configured to provide negative-pressure to the sealed space. One or more sealing tape may be coupled to the drape and epidermis adjacent to the tissue site. The sealing tape may each have a bonding adhesive configured to form a bonding coupling and a sealing adhesive configured to form a sealing coupling coupled to a side of the sealing tape.
- According to yet another illustrative embodiment, a method for manufacturing sealing tape for a negative-pressure system is described. The method provides a film layer and couples a layer of a bonding adhesive to the film layer. The method couples a layer of a sealing adhesive to the bonding layer. The method removes portions of the sealing adhesive to form a first pattern and expose the bonding adhesive through the sealing adhesive in a second pattern.
- According to still another illustrative embodiment, a method for manufacturing sealing tape for a negative-pressure system is described. A film layer may be provided and a bonding adhesive may be disposed on a first portion of the film layer in a first pattern. A sealing adhesive may be disposed on a second portion of the film layer in a second pattern. The second pattern may be registered with the first pattern so that the first portion and the second portion cover substantially different portions of the film layer.
- Other aspects, features, and advantages of the illustrative embodiments will become apparent with reference to the drawings and detailed description that follow.
- Illustrative embodiments are described in detail below with reference to the attached drawings, which are incorporated by reference herein, and wherein:
-
FIG. 1A is a schematic diagram (with a portion shown in elevation) of an illustrative embodiment of a system for treating a tissue site on a patient with negative pressure that may be associated with some illustrative embodiments of the system; -
FIG. 1B is a plan view of a portion of the system ofFIG. 1A ; -
FIG. 2A is a schematic diagram (with a portion shown in elevation) of another illustrative embodiment of a system for treating a tissue site on a patient with negative pressure; -
FIG. 2B is a plan view of a portion of the system ofFIG. 2A ; -
FIG. 3 is an exploded perspective view of a sealing tape that may be used with some embodiments of the systems ofFIG. 1A andFIG. 2A ; -
FIG. 4A is a sectional view of a portion of the sealing tape ofFIG. 3 with sealing couplings; -
FIG. 4B is a sectional view of the portion of the sealing tape ofFIG. 4A with bonding couplings; -
FIG. 5 is an exploded perspective view of a sealing tape that may be used with the systems ofFIG. 1A andFIG. 2A ; -
FIG. 6 is a sectional view of a portion of the sealing tape ofFIG. 5 proximate to an epidermis; -
FIG. 7 is a sectional view of the portion of the sealing tape ofFIG. 6 with sealing couplings; -
FIG. 8 is a sectional view of the portion of the sealing tape ofFIG. 6 with bonding couplings; and -
FIG. 9 ,FIG. 10 ,FIG. 11 ,FIG. 12 ,FIG. 13 ,FIG. 14 , andFIG. 15 are plan views of illustrative patterns of the sealing tape ofFIG. 3 andFIG. 5 . - New and useful systems, methods, and apparatuses associated with drapes used for regulating pressure are set forth in the appended claims. Objectives, advantages, and a preferred mode of making and using the systems, methods, and apparatuses may be understood best by reference to the following detailed description in conjunction with the accompanying drawings. The description provides information that enables a person skilled in the art to make and use the claimed subject matter, but may omit certain details already well-known in the art. Moreover, descriptions of various alternatives using terms such as “or” do not necessarily require mutual exclusivity unless clearly required by the context. The claimed subject matter may also encompass alternative embodiments, variations, and equivalents not specifically described in detail. The following detailed description should therefore be taken as illustrative and not limiting.
- The example embodiments may also be described herein in the context of negative-pressure therapy applications, but many of the features and advantages are readily applicable to other environments and industries. Spatial relationships between various elements or to the spatial orientation of various elements may be described as depicted in the attached drawings. In general, such relationships or orientations assume a frame of reference consistent with or relative to a patient in a position to receive negative-pressure therapy. However, as should be recognized by those skilled in the art, this frame of reference is merely a descriptive expedient rather than a strict prescription.
-
FIG. 1A is a sectional view of an example embodiment of a negative-pressure therapy system 100 illustrating details that may be associated with some embodiments for treating atissue site 102 with negative pressure. As shown in the illustrative embodiment ofFIG. 1A , the negative-pressure therapy system 100 may include a dressing 104 fluidly coupled to a negative-pressure source 106. In some embodiments, the negative-pressure source 106 may be fluidly coupled to the dressing 104 by a conduit, such as atube 112, and a connector, such as aconnector 114. The dressing 104 may generally include a cover or sealing member, such as adrape 108, and a tissue interface, such as atissue interface 110. Thedrape 108 may be attached to anepidermis 116. Thedrape 108 can substantially prevent the leakage of fluids while allowing vapor to egress through thedrape 108. In some embodiments, the dressing 104 may include one ormore sealing tape 124 coupled toepidermis 116 and thedrape 108. - In general, components of the negative-
pressure therapy system 100 may be coupled directly or indirectly to each other. For example, the negative-pressure source 106 may be directly coupled to theconnector 114 and indirectly coupled to thetissue interface 110 through theconnector 114. Components may be fluidly coupled to each other to provide a path for transferring fluids (i.e., liquid and/or gas) between the components. - In some embodiments, components may be fluidly coupled with a tube, such as the
tube 112, for example. A “tube,” as used herein, broadly refers to a tube, pipe, hose, conduit, or other structure with one or more lumina adapted to convey fluids between two ends. Typically, a tube is an elongated, cylindrical structure with some flexibility, but the geometry and rigidity may vary. In some embodiments, components may additionally or alternatively be coupled by virtue of physical proximity, being integral to a single structure, or being formed from the same piece of material. Coupling may also include mechanical, thermal, electrical, or chemical coupling (such as a chemical bond) in some contexts. - In operation, a tissue interface, such as the
tissue interface 110, may be placed within, over, on, against, or otherwise proximate to a tissue site. Thedrape 108 may be sealed to undamaged epidermis peripheral to the tissue site. Thus, thedrape 108 can provide a sealedtherapeutic environment 118 proximate to thetissue site 102. The sealedtherapeutic environment 118 may be substantially isolated from the external environment, and the negative-pressure source 106 can reduce the pressure in the sealedtherapeutic environment 118. Negative pressure applied across the tissue site through a tissue interface in the sealedtherapeutic environment 118 can induce macrostrain and microstrain in thetissue site 102, as well as remove exudates and other fluids from the tissue site. The removed exudates and other fluids can be collected in a container and disposed of properly. - The fluid mechanics of using a negative-pressure source to reduce pressure in another component or location, such as within a sealed
therapeutic environment 118, can be mathematically complex. However, the basic principles of fluid mechanics applicable to negative-pressure therapy are generally well-known to those skilled in the art, and the process of reducing pressure may be described illustratively herein as “delivering,” “distributing,” or “generating” negative pressure, for example. - In general, exudates and other fluids flow toward lower pressure along a fluid path. Thus, the term “downstream” typically implies a position in a fluid path relatively closer to a negative-pressure source, and conversely, the term “upstream” implies a position relatively further away from a negative-pressure source. Similarly, it may be convenient to describe certain features in terms of fluid “inlet” or “outlet” in such a frame of reference. This orientation is generally presumed for purposes of describing various features and components of negative-pressure therapy systems herein. However, a fluid path may also be reversed in some applications, such as by substituting a positive-pressure source for a negative-pressure source, and this descriptive convention should not be construed as a limiting convention.
- The term “tissue site” in this context broadly refers to a wound or defect located on or within tissue, including but not limited to, bone tissue, adipose tissue, muscle tissue, neural tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons, or ligaments. A wound may include chronic, acute, traumatic, subacute, and dehisced wounds, partial-thickness burns, ulcers (such as diabetic, pressure, or venous insufficiency ulcers), flaps, and grafts, for example. The term “tissue site” may also refer to areas of tissue that are not necessarily wounded or defective, but are instead areas in which it may be desirable to add or promote the growth of additional tissue. For example, negative pressure may be used in certain tissue areas to grow additional tissue that may be harvested and transplanted to another tissue location. In some embodiments, the
tissue site 102 may be a wound that extends through theepidermis 116, through adermis 120, and intosubcutaneous tissue 122. - “Negative pressure” generally refers to a pressure less than a local ambient pressure, such as the ambient pressure in a local environment external to the sealed
therapeutic environment 118 provided by thedrape 108. In many cases, the local ambient pressure may also be the atmospheric pressure at which a tissue site is located. Alternatively, the pressure may be less than a hydrostatic pressure associated with tissue at the tissue site. Unless otherwise indicated, values of pressure stated herein are gauge pressures. Similarly, references to increases in negative pressure typically refer to a decrease in absolute pressure, while decreases in negative pressure typically refer to an increase in absolute pressure. - A negative-pressure source, such as the negative-
pressure source 106, may be a reservoir of air at a negative pressure, or may be a manual or electrically-powered device that can reduce the pressure in a sealed volume, such as a vacuum pump, a suction pump, a wall-suction port available at many healthcare facilities, or a micro-pump, for example. A negative-pressure source may be housed within or used in conjunction with other components, such as sensors, processing units, alarm indicators, memory, databases, software, display devices, or operator interfaces that further facilitate negative-pressure therapy. While the amount and nature of negative pressure applied to a tissue site may vary according to therapeutic requirements, the pressure is generally a low vacuum, also commonly referred to as a rough vacuum between −5 mm Hg (−667 Pa) and −500 mm Hg (−66.7 kPa). Common therapeutic ranges are between −75 mm Hg (−9.9 kPa) and −300 mm Hg (−39.9 kPa). - The
tissue interface 110 can be generally adapted to contact a tissue site. Thetissue interface 110 may be partially or fully in contact with the tissue site. If the tissue site is a wound, for example, thetissue interface 110 may partially or completely fill the wound, or may be placed over the wound. Thetissue interface 110 may take many forms, and may have many sizes, shapes, or thicknesses depending on a variety of factors, such as the type of treatment being implemented or the nature and size of a tissue site. For example, the size and shape of thetissue interface 110 may be adapted to the contours of deep and irregular shaped tissue sites. - In some embodiments, the
tissue interface 110 may be a manifold. A “manifold” in this context generally includes any substance or structure providing a plurality of pathways adapted to collect or distribute fluid across a tissue site under negative pressure. For example, a manifold may be adapted to receive negative pressure from a source and distribute the negative pressure through multiple apertures across a tissue site, which may have the effect of collecting fluid from across a tissue site and drawing the fluid toward the source. In some embodiments, the fluid path may be reversed or a secondary fluid path may be provided to facilitate delivering fluid across a tissue site. - In some illustrative embodiments, the pathways of a manifold may be channels interconnected to improve distribution or collection of fluids across a tissue site. For example, cellular foam, open-cell foam, reticulated foam, porous tissue collections, and other porous material such as gauze or felted mat generally include pores, edges, and/or walls adapted to form interconnected fluid pathways. Liquids, gels, and other foams may also include or be cured to include apertures and flow channels. In some illustrative embodiments, a manifold may be a porous foam material having interconnected cells or pores adapted to distribute negative pressure across a tissue site. The foam material may be either hydrophobic or hydrophilic. In one non-limiting example, a manifold may be an open-cell, reticulated polyurethane foam such as GranuFoam® dressing available from Kinetic Concepts, Inc. of San Antonio, Tex.
- In an example in which the
tissue interface 110 may be made from a hydrophilic material, thetissue interface 110 may also wick fluid away from a tissue site, while continuing to distribute negative pressure to the tissue site. The wicking properties of thetissue interface 110 may draw fluid away from a tissue site by capillary flow or other wicking mechanisms. An example of a hydrophilic foam is a polyvinyl alcohol, open-cell foam such as V.A.C. WhiteFoam® dressing available from Kinetic Concepts, Inc. of San Antonio, Tex. Other hydrophilic foams may include those made from polyether. Other foams that may exhibit hydrophilic characteristics include hydrophobic foams that have been treated or coated to provide hydrophilicity. - The
tissue interface 110 may further promote granulation at a tissue site when pressure within the sealedtherapeutic environment 118 is reduced. For example, any or all of the surfaces of thetissue interface 110 may have an uneven, coarse, or jagged profile that can induce microstrains and stresses at a tissue site if negative pressure is applied through thetissue interface 110. - In some embodiments, the
tissue interface 110 may be constructed from bioresorbable materials. Suitable bioresorbable materials may include, without limitation, a polymeric blend of polylactic acid (PLA) and polyglycolic acid (PGA). The polymeric blend may also include without limitation polycarbonates, polyfumarates, and capralactones. Thetissue interface 110 may further serve as a scaffold for new cell-growth, or a scaffold material may be used in conjunction with thetissue interface 110 to promote cell-growth. A scaffold is generally a substance or structure used to enhance or promote the growth of cells or formation of tissue, such as a three-dimensional porous structure that provides a template for cell growth. Illustrative examples of scaffold materials include calcium phosphate, collagen, PLA/PGA, coral hydroxy apatites, carbonates, or processed allograft materials. - The
drape 108 is an example of a sealing member. A sealing member may be constructed from a material that can provide a fluid seal between two environments or components, such as between a therapeutic environment and a local external environment. A sealing member may be, for example, an impermeable or semi-permeable, elastomeric film or barrier that can provide a seal adequate to maintain a negative pressure at a tissue site for a given negative-pressure source. For semi-permeable materials, the permeability generally should be low enough that a desired negative pressure may be maintained. Generally, a drape suitable for covering a tissue site for negative-pressure therapy may comprise a film having a thickness between about 25 microns and about 50 microns that is water-vapor permeable and formed of a polymer. The film, often formed of polyurethane, may be coated with an adhesive having a coating weight between about 25 gsm and about 65 gsm. The adhesive may often be acrylic-based and pressure sensitive. A pressure-sensitive adhesive increases in bond strength when pressed against the surface to which the adhesive is being bonded. In some applications, a pressure-sensitive adhesive may undergo a physical change when compressed against a surface. In other applications, a pressure-sensitive adhesive may flow into crevices of a surface when compressed, increasing the bond strength without undergoing a physical change. - An attachment device may be used to attach a sealing member to an attachment surface, such as undamaged epidermis, a gasket, or another sealing member. The attachment device may take many forms. For example, an attachment device may be a medically-acceptable, pressure-sensitive adhesive that extends about a periphery, a portion, or an entire sealing member. In some embodiments, the attachment device may be an acrylic-based pressure sensitive adhesive having a coating weight between about 25 grams/m2 (gsm) and about 60 gsm. Other example embodiments of an attachment device may include a double-sided tape, paste, hydrocolloid, hydrogel, silicone gel, organogel, or an acrylic adhesive.
- A “container” broadly includes a canister, pouch, bottle, vial, or other fluid collection apparatus. A container, for example, can be used to manage exudates and other fluids withdrawn from a tissue site. In many environments, a rigid container may be preferred or required for collecting, storing, and disposing of fluids. In other environments, fluids may be properly disposed of without rigid container storage, and a re-usable container could reduce waste and costs associated with negative-pressure therapy.
- A
connector 114 may be used to fluidly couple thetube 112 to the sealedtherapeutic environment 118. The negative pressure developed by the negative-pressure source 106 may be delivered through thetube 112 to theconnector 114. In one illustrative embodiment, theconnector 114 may be a T.R.A.C.® Pad or Sensa T.R.A.C.® Pad available from KCI of San Antonio, Tex. Theconnector 114 allows the negative pressure to be delivered to the sealedtherapeutic environment 118. In other exemplary embodiments, theconnector 114 may also be a tube inserted through thedrape 108. The negative pressure may also be generated by a device directly coupled to thedrape 108, such as a micropump. - The provision of negative-pressure therapy with negative-pressure therapy systems, such as the negative-
pressure therapy system 100, is increasingly being performed with smaller therapy devices that use battery power rather than a connection to an electrical outlet. Use of battery power decreases the total power supply available to a therapy device. As a result, power drains that would be considered negligible in a device powered through an electrical outlet connection may significantly reduce the ability of the therapy device to provide therapy. A power drain refers to operation of the therapy device that requires use of electrical power, for example, operation of a pump to generate negative pressure. Power drains may be caused by low-level dressing leaks, for example. A low-level dressing leak can drain power from a battery of a therapy device by repeatedly triggering operation of the therapy device to maintain the necessary negative pressure at the tissue site. Power drains can shorten the useful life of the therapy device by draining the device battery faster, requiring more frequent disposal of the device, recharging of the battery, or battery replacement. Leak detection techniques may help to identify some leaks that may be sealed by the user; however, low-level leaks will challenge the most sensitive leak detection systems and may often go undetected. - Low-level dressing leaks may occur between a drape and epidermis surrounding a tissue site if the drape fails to completely seal to the epidermis. Generally, a drape may include an adhesive having a strength sufficient to seal against leaks but that may also cause pain to a patient if the drape is removed. A drape using an acrylic adhesive as described above is generally suitable for a dressing if a negative-pressure source powered by a continuous power supply can compensate for a leak.
- Some drapes may use a bonding adhesive an alternative to an acrylic adhesive. A bonding adhesive may have a bond strength that is greater than the bond strength of the standard acrylic adhesive. A bonding adhesive may be better for sealing than a standard acrylic adhesive, but the bond strength would cause significantly more discomfort if the drape is removed. In addition, removing a drape having a bonding adhesive may cause significant damage to patients having delicate or damaged skin.
- A drape that has a sealing adhesive can fill gaps between the drape and the epidermis to limit leaks and can be easy to remove with low discomfort to the patient. Various sealing, gap-filling adhesives, such as silicone, hydrocolloids, and hydrogels, have been tried but each has drawbacks. For example, hydrogel adhesives are usually low tack and prone to swelling, creep, and mobility when used with fluid systems. Available hydrogels and hydrocolloids do not adhere well and may move when anchored. In another example, silicone adhesives can fill gaps and seal, but are not breathable and may lose the necessary mechanical bonding strength as the silicone adhesives interact with moisture during use.
- A hybrid drape having a thick sealing layer that is perforated and laminated over an adhesive coated film can overcome many of these challenges. For example, a hybrid drape may include a film layer having a bonding adhesive applied directly to the film layer, and a sealing adhesive applied directly to the bonding adhesive. The sealing adhesive can be perforated to expose the bonding adhesive. When the drape is applied to a patient, the bonding adhesive can be pushed through the perforations of the sealing adhesive to secure the sealing adhesive to the patient. This laminated configuration may provide the benefits of the sealing adhesive and the bonding adhesive over the entire drape area. For example, the laminated configuration can seal typical low-level leaks and mechanically affix to the epidermis without secondary processes. The laminated configuration may also require minimal additional application care by the user and can be removable with minimal trauma to the patient. However, construction of the laminated configuration requires additional assembly steps and an increase in materials that may significantly increase costs.
- Other hybrid drapes may register a bonding adhesive and a sealing adhesive. These hybrid drapes apply both the bonding adhesive and the sealing adhesive directly to a film layer. The bonding adhesive and the sealing adhesive may each cover different portions of the film layer to reduce the overall thickness of the hybrid drape and decrease the amount of adhesive needed to construct the hybrid drape. However, the complexity of the manufacturing process may also have increased costs relative to a non-hybrid drape.
- For some negative-pressure therapies, a standard drape having a standard acrylic adhesive may be used while treatment occurs in a care facility, such as a hospital. The negative-pressure therapy may be performed using a wall-powered negative-pressure source. Often, a patient may be discharged from a care facility before negative-pressure therapy concludes. Negative-pressure therapy may continue outside of the care facility using a portable negative-pressure source. A hybrid drape may be applied to address leaking issues that may arise with a portable negative-pressure source. However, it may be disadvantageous to change the dressing during the transition. For example, changing the dressing may increase the cost of negative-pressure therapy by requiring additional dressings to be used. Changing the dressing may also cause additional irritation to the tissue site, which may negatively impact healing of the tissue site and patient comfort.
- As disclosed herein, the negative-
pressure therapy system 100 can overcome these challenges and others by providing the sealingtape 124 having a hybrid adhesive configuration. In some embodiments, the sealingtape 124 may have two adhesives, a bonding adhesive and a sealing adhesive. As shown inFIG. 1A , the sealingtape 124 may be applied to thedrape 108 so that the sealingtape 124 may partially couple to thedrape 108 and partially couple to theepidermis 116, covering an edge of thedrape 108. The sealingtape 124 may provide increased sealing of thedrape 108 to theepidermis 116. -
FIG. 1B is a plan view of the dressing 104 illustrating additional details that may be associated with some embodiments. As shown, thetissue interface 110 may be disposed at thetissue site 102 and covered with thedrape 108 to form the sealedtherapeutic environment 118. The sealingtape 124 may be positioned to cover edges of thedrape 108. In some embodiments, the sealingtape 124 may be partially coupled to thedrape 108 and partially coupled to theepidermis 116. In some embodiments, ends of the sealingtape 124 may overlap one another. -
FIG. 2A is a sectional view of the negative-pressure therapy system 100 for treating thetissue site 102 with negative pressure illustrating details that may be associated another embodiment. In some embodiments, the sealingtape 124 may be applied directly to theepidermis 116 adjacent to thetissue site 102. Thedrape 108 may be coupled directly to the sealingtape 124. The sealingtape 124 may provide a stronger bond to theepidermis 116 and a better surface for thedrape 108 to seal to, decreasing the size of the leaks through the dressing 104. Thedrape 108 may bond directly to a surface of the sealingtape 124 opposite theepidermis 116. The surface of the sealingtape 124 may be formed of a material to which the standard adhesive of thedrape 108 may bond to more readily than theepidermis 116. In addition, the surface of the drapes strips 124 may have fewer crevices, bumps, and cracks than theepidermis 116, providing a better bonding surface for thedrape 108. -
FIG. 2B is a plan view of the dressing 104 illustrating additional details that may be associated with some embodiments. As shown, thetissue interface 110 may be disposed at thetissue site 102. The sealingtape 124 may be disposed around thetissue site 102 to form awindow 125, thetissue site 102 being within boundaries of thewindow 125. In some embodiments, thewindow 125 may be an area of tissue having peripheral portions bounded by the sealingtape 124. In some embodiments, four sealingtape 124 may be disposed on theepidermis 116 so that thewindow 125 has a square shape having thetissue site 102 within thewindow 125. In other embodiments, more orfewer sealing tape 124 may be used as needed and may form other shapes. In some embodiments, the sealingtape 124 may couple directly to theepidermis 116. Thedrape 108 may then be coupled at least to the sealingtape 124 to cover thetissue site 102 and thetissue interface 110 to form the sealedtherapeutic environment 118. In some embodiments, ends of the sealingtape 124 may overlap. In other embodiments, the sealingtape 124 may be cut so that ends of the sealingtape 124 do not overlap. -
FIG. 3 is an exploded perspective view of the sealingtape 124, illustrating details that may be associated with some embodiments. In some embodiments, the sealingtape 124 may include afilm layer 126, a layer of abonding adhesive 128, and a layer of a sealingadhesive 130. Thefilm layer 126 may be liquid-impermeable and vapor-permeable, that is, thefilm layer 126 may allow vapor to egress and inhibit liquids from exiting. Thefilm layer 126 may be a flexible film that is breathable and may have a high moisture vapor transfer rate (MVTR), for example, greater than or equal to about 300 g/m2/24 hours. Thefilm layer 126 may be formed from a range of medically approved films ranging in thickness typically from about 15 microns (μm) to about 50 microns (μm). In other embodiments, a drape having a low MVTR or that allows no vapor transfer might be used. In some embodiments, thefilm layer 126 can also function as a barrier to liquids and microorganisms. - The
film layer 126 may be formed from numerous materials, such as one or more of the following: hydrophilic polyurethane (PU), cellulosics, hydrophilic polyamides, polyvinyl alcohol, polyvinyl pyrrolidone, hydrophilic acrylics, hydrophilic silicone elastomers, and copolymers of these. In some embodiments, thefilm layer 126 may be formed from a breathable cast matt polyurethane film sold by Expopack Advanced Coatings of Wrexham, United Kingdom, under the name INSPIRE 2301. The illustrative film may have an MVTR (inverted cup technique) of 14400 g/m2/24 hours and may be approximately 30 microns thick. - The
bonding adhesive 128 may be coupled directly to thefilm layer 126. In some embodiments, thebonding adhesive 128 and thefilm layer 126 may be coextensive. In other embodiments, thebonding adhesive 128 and thefilm layer 126 may not be coextensive. A bonding adhesive may be a medically-acceptable, pressure-sensitive adhesive. For example, a bonding adhesive may be formed from an acrylic adhesive, rubber adhesive, high-tack silicone adhesive, polyurethane, or other substance. In some embodiments, a bonding adhesive may be formed from an acrylic adhesive with a coating weight of about 15 gsm to about 70 gsm. A bonding adhesive may also be a high-bond strength acrylic adhesive, patterrubber adhesive, high-tack silicone adhesive, or polyurethane, for example. In some embodiments, the bond strength or tackiness of a bonding adhesive may have a peel adhesion or resistance to being peeled from a stainless steel material between about 6 Newtons/25 millimeters (N/mm) to about 10N/25 mm on stainless steel substrate at 23° C. at 50% relative humidity based on the American Society for Testing and Materials (“ASTM”) standard ASTM D3330. - The
bonding adhesive 128 may be a continuous layer of material or may be a layer with apertures (not shown). The apertures may be formed after application of thebonding adhesive 128 or may be formed by coating thebonding adhesive 128 in patterns on a carrier layer. The apertures may be sized to help control the resultant tackiness of thebonding adhesive 128. The apertures may also be sized to enhance the MVTR of the sealingtape 124. Thebonding adhesive 128 may couple thefilm layer 126 to the sealingadhesive 130. - The sealing adhesive 130 has a
thickness 132 that may be in the range of about 100 microns (μm) to about 1000 microns (μm). A sealing adhesive may be a soft material that provides a good seal with thetissue site 102. A sealing adhesive may be formed of a silicone gel (or soft silicone), hydrocolloid, hydrogel, polyurethane gel, polyolefin gel, hydrogenated styrenic copolymer gels, or foamed gels with compositions as listed, or soft closed cell foams (polyurethanes, polyolefins) coated with an adhesive (e.g., 30 gsm-70 gsm acrylic), polyurethane, polyolefin, or hydrogenated styrenic copolymers. In some embodiments, a sealing adhesive may have a stiffness between about 5 Shore 00 and about 80 Shore 00. A sealing adhesive may be hydrophobic or hydrophilic. A sealing adhesive may be an adhesive having a low to medium tackiness, for example, a silicone polymer, polyurethane, or an additional acrylic adhesive. In some embodiments, the bond strength or tackiness of a sealing adhesive may have a peel adhesion or resistance to being peeled from a stainless steel material between about 0.5N/25 mm to about 1.5N/25 mm on stainless steel substrate at 23° C. at 50% relative humidity based on ASTM D3330. A sealing adhesive may achieve the bond strength above after a contact time of less than 60 seconds. Tackiness may be considered a bond strength of an adhesive after a very low contact time between the adhesive and a substrate. In some embodiments, a sealing adhesive may have a tackiness that may be about 30% to about 50% of the tackiness of a bonding adhesive. - The sealing adhesive 130 may be formed with a plurality of
apertures 134. Theapertures 134 may be numerous shapes, for example, circles, squares, stars, ovals, polygons, slits, complex curves, rectilinear shapes, triangles, or other shapes. Eachaperture 134 of the plurality ofapertures 134 may have an effective diameter. An effective diameter may be a diameter of a circular area having the same surface area as theaperture 134. The average effective diameter of eachaperture 134 may be in the range of about 6 mm to about 50 mm. Theapertures 134 may have a uniform pattern or may be randomly distributed on the sealingadhesive 130. For example, in some embodiments, theapertures 134 may be distributed so that theapertures 134 extend to edges of the sealingtape 124. In other embodiments, theapertures 134 may be distributed so that a portion of the sealing adhesive 130 includes noapertures 134. -
FIG. 4A is a sectional view of a portion of the sealingtape 124 illustrating additional details that may be associated with some embodiments. In the assembled state, thebonding adhesive 128 may be coupled to thefilm layer 126, and the sealing adhesive 130 may be coupled to thebonding adhesive 128. If the sealing adhesive 130 is placed proximate to or in contact with theepidermis 116, the sealing adhesive 130 may form sealingcouplings 131 with theepidermis 116. In some embodiments, thethickness 132 of the sealing adhesive 130 may create agap 133 between the bonding adhesive 128 and theepidermis 116. -
FIG. 4B is a sectional view of the sealingtape 124 illustrating additional details that may be associated with some embodiments. If the sealingtape 124 is in a desired location, pressure may be applied to thefilm layer 126. The pressure may cause thebonding adhesive 128 to be pressed at least partially into contact with theepidermis 116 to formbonding couplings 136. Thebonding couplings 136 may provide secure, releasable mechanical fixation to theepidermis 116. The sealingcouplings 131 between the sealing adhesive 130 and theepidermis 116 may be sufficient to seal thefilm layer 126 to theepidermis 116. The sealingcouplings 131 may not be as mechanically strong as thebonding couplings 136 between the bonding adhesive 128 and theepidermis 116. Thebonding couplings 136 may also anchor the sealingtape 124 to theepidermis 116, inhibiting migration of the sealingtape 124 and the sealingadhesive 130. - The average effective diameter of the
apertures 134 of the sealing adhesive 130 may be varied as one control of the tackiness or adhesion strength of the sealingtape 124. In this regard, there is interplay between three main variables for each embodiment: thethickness 132, the average effective diameter of the plurality ofapertures 134, and the tackiness of thebonding adhesive 128. Themore bonding adhesive 128 that extends through theapertures 134, the stronger the bond of thebonding coupling 136. The smaller thethickness 132 of the sealing adhesive 130, the more bonding adhesive 128 generally extends through theapertures 134 and the greater the bond of thebonding coupling 136. As an example of the interplay, if a very tacky bonding adhesive 128 is used and thethickness 132 of the sealing adhesive 130 is small, the average effective diameter of the plurality ofapertures 134 may be relatively smaller. In some embodiments, thethickness 132 may be approximately 200 microns, thebonding adhesive 128 may be approximately 30 microns, have a tackiness of 2000 g/25 cm wide strip, and the average effective diameter may be about 6 mm. -
FIG. 5 is an exploded perspective view of the sealingtape 124 illustrating additional details that may be associated with some embodiments. The sealingtape 124 may include thefilm layer 126 and anadhesive layer 138 adjacent to thefilm layer 126. -
FIG. 6 is an exploded cross sectional view of the sealingtape 124 illustrating additional details that may be associated with some embodiments. Thefilm layer 126 may have afirst side 140 and asecond side 142. Theadhesive layer 138 may be coupled to thesecond side 142 of thefilm layer 126. Theadhesive layer 138 may be a medically-acceptable, pressure-sensitive adhesive, glue, bonding agent, or cement, for example. In some embodiments, two adhesives having different characteristics may be used to form theadhesive layer 138. For example, theadhesive layer 138 may include a first adhesive such as thebonding adhesive 128 and a second adhesive such as the sealingadhesive 130. In some embodiments, the placement of thebonding adhesive 128 and the sealing adhesive 130 may be coordinated so that thebonding adhesive 128 and the sealing adhesive 130 both couple directly to thesecond side 142 of thefilm layer 126. - The
bonding adhesive 128 may be disposed on thefilm layer 126 in a pattern and may be about 30 microns to about 60 microns in thickness. In a non-limiting illustrative example, thebonding adhesive 128 of theadhesive layer 138 comprises an acrylic adhesive with coating weight of 15 grams/m2 (gsm) to 70 grams/m2 (gsm). In some embodiments, the sealing adhesive 130 may be disposed on thefilm layer 126 in a pattern and may be about 100 microns to about 400 microns thick. In some embodiments, theadhesive layer 138 may partially cover thesecond side 142 of thefilm layer 126, leaving portions of thesecond side 142 of thefilm layer 126 free of adhesive. In other embodiments, theadhesive layer 138 may be coextensive with thesecond side 142 of thefilm layer 126. -
FIG. 7 is a sectional view of the sealingtape 124 illustrating additional details that may be associated with some embodiments. In some embodiments, the thickness of thebonding adhesive 128 may be less than the thickness of the sealing adhesive 130 so that theadhesive layer 138 may have a varying thickness. If theadhesive layer 138 is applied to theepidermis 116, the sealing adhesive 130 may can form the sealingcouplings 131 with theepidermis 116. In some embodiments, the thickness of thebonding adhesive 128 may be less than the thickness of the sealing adhesive 130, forming thegap 133 between the bonding adhesive 128 and theepidermis 116. -
FIG. 8 is a sectional view of the sealingtape 124 illustrating additional details that may be associated with some embodiments. If the sealingtape 124 is in a desired location, pressure may be applied to thefirst side 140 of thefilm layer 126. The pressure may cause thebonding adhesive 128 to be pressed at least partially into contact with theepidermis 116 to form thebonding couplings 136. Thebonding couplings 136 can provide secure, releasable mechanical fixation to theepidermis 116. The sealingcouplings 131 between the sealing adhesive 130 and theepidermis 116 may be sufficient to seal thefilm layer 126 to theepidermis 116. The sealingcouplings 131 may not be as mechanically strong as thebonding couplings 136 between the bonding adhesive 128 and theepidermis 116. - According to an illustrative embodiment of the
drape 108 in the context of the negative-pressure therapy system 100, thetissue interface 110 may be disposed proximate to thetissue site 102. In some embodiments, thedrape 108 may be disposed over thetissue interface 110 and theepidermis 116 to form the sealedtherapeutic environment 118. The sealingtape 124 may be applied to the edge of thedrape 108 so that a width of each sealingtape 124 overlaps an edge of thedrape 108. In some embodiments, each sealingtape 124 may partially cover thedrape 108 and partially cover theepidermis 116. Thebonding adhesive 128 of the sealingtape 124 may form bondingcouplings 136 with theepidermis 116 and a top surface of thedrape 108, while the sealing adhesive 130 may form sealingcouplings 131 with theepidermis 116 and the top surface of thedrape 108. In some embodiments, thebonding couplings 136 may have a peel force against theepidermis 116 between about 0.5N/25 mm to about 2N/25 mm. In this manner, the sealingtape 124 may seal the edges of thedrape 108, decreasing leaks between thedrape 108 and theepidermis 116. - In another illustrative embodiment, the
tissue interface 110 may be disposed proximate to thetissue site 102. One ormore sealing tape 124 may be disposed around thetissue site 102 to form thewindow 125 containing thetissue site 102. The sealingadhesive 130 of each sealingtape 124 may form the sealingcouplings 131 with theepidermis 116, and thebonding adhesive 128 of each sealingtape 124 may form thebonding couplings 136 with theepidermis 116. In some embodiments, thebonding couplings 136 may have a peel force against theepidermis 116 between about 0.5N/25 mm to about 2N/25 mm. Thedrape 108 may be disposed over thetissue interface 110 and theepidermis 116 and coupled to the sealingtape 124 to form the sealedtherapeutic environment 118. Thebonding couplings 136 and the sealingcouplings 136 of the sealingtape 124 may seal the sealingtape 124 to theepidermis 116. Thedrape 108 may be coupled to thefilm layer 126 of the sealingtape 124. Thefirst surface 140 of thefilm layer 126 may provide a bonding surface that is more suitable for adhesion by the standard adhesive of thedrape 108 than theepidermis 116. In this manner, the sealingtape 124 may decrease instances of leaks between thedrape 108 and theepidermis 116. - As shown in
FIG. 6 ,FIG. 7 , andFIG. 8 , the pattern of thebonding adhesive 128 and the pattern of the sealing adhesive 130 may be registered. Registration of thebonding adhesive 128 and the sealing adhesive 130 generally refers to the alignment of the two adhesives relative to one another. In particular, registration of thebonding adhesive 128 and the sealing adhesive 130 may refer to the coordination of adhesive placement on thefilm layer 126 to achieve a desired effect. For example, a certain percentage of overlap of one adhesive over the other adhesive, minimal overlap of one adhesive over the other adhesive so that the adhesives are offset from one another, or complete overlap of one adhesive over the other adhesive are all adhesive placements that may be considered registered. For example, thebonding adhesive 128 and the sealing adhesive 130 may be registered by being disposed on thesecond side 142 of thefilm layer 126 so that thebonding adhesive 128 and the sealing adhesive 130 each substantially couple to thesecond side 142 of thefilm layer 126. In addition, thebonding adhesive 128 and the sealingadhesive 130 of the example may be aligned relative to one another to have minimal overlap of one adhesive over the other adhesive. In another example, the sealing adhesive 130 may be offset from thebonding adhesive 128, with both adhesives being coupled to thesecond side 142 of thefilm layer 126. Registering thebonding adhesive 128 and the sealing adhesive 130 can provide for easier manufacturing and use of the sealingtape 124. Registering of thebonding adhesive 128 and the sealing adhesive 130 may also enhance desired properties of the sealingtape 124 as described in more detail below. Illustrative, but non-limiting, examples of the registration of thebonding adhesive 128 and the sealing adhesive 130 may be described in more detail with respect to the following embodiments. -
FIG. 9 is a plan view of the sealingtape 124 illustrating additional details that may be associated with some embodiments. The sealingtape 124 may have awidth 160 and alength 162. In some embodiments, thewidth 160 may be between about 20 mm. In other embodiments, thewidth 160 may be between about 10 mm to about 30 mm. In some embodiments, thelength 162 may be up to about 200 mm. The sealingtape 124 may be cut or torn so that a sealingtape 124 having thelength 162 suitable for use may be provided. For example, a sealingtape 124 may be provided in rolls, allowing a clinician to select a length suitable for a particular tissue site and cut or tear an end of the sealingtape 124 to remove it from the roll. The sealingtape 124 may also include thebonding adhesive 128 and the sealing adhesive 130 havingapertures 134. In some embodiments, thebonding adhesive 128 may have a coating weight of about 25 gsm. In some embodiments, the sealing adhesive 130 may have a coating weight of about 100 gsm to about 600 gsm. In some embodiments, theapertures 134 may have a diameter between about 7 mm to about 10 mm. In other embodiments, theapertures 134 may have a diameter between about 5 mm to about 30 mm. In some embodiments, the sealingtape 124 may include two rows ofapertures 134 that may be offset from one another. In some embodiments, theapertures 134 may be evenly distributed on the sealingtape 124. -
FIG. 10 is a plan view of a sealingtape 224 illustrating additional details that may be associated with some embodiments. The sealingtape 224 may be similar to and operate in a manner similar to the sealingtape 124 ofFIG. 9 . Similar elements have been indexed to 200. For example, the sealingtape 224 may have awidth 260, alength 262, a layer of abonding adhesive 228, a layer of a sealing adhesive 230, and apertures 234. The apertures 234 may be positioned similar to theapertures 134. In some embodiments, the sealingadhesive 230 of the sealingtape 224 may includeedge apertures 235. If the apertures 234 are circles, as shown, theedge apertures 235 may be semi-circles having a radius equal to a radius of the apertures 234. The edge apertures 235 may be positioned so that a diameter of eachedge aperture 235 is adjacent to an edge of the sealingtape 224 that is parallel to thelength 262. In some embodiments, theedge apertures 235 may be disposed along both edges. In other embodiments, theedge apertures 235 may only be disposed along one edge. The apertures 234 and theedge apertures 235 may be evenly distributed on the sealingtape 224. For example, each aperture 234 andedge aperture 235 may be separated from adjacent apertures 234 andedge apertures 235 by a same distance. In some embodiments, an even distribution may produce a sealingtape 224 having apertures 234 andapertures 235 extending between edges of the sealingtape 224 at regularly repeating distances. Theapertures 235 may expose a portion of thebonding adhesive 228 at the edges of the sealingtape 224. Exposure of thebonding adhesive 228 proximate to the edge of the sealingtape 224 may aid in resistance to edge lifting during use of the sealingtape 224. Edge lifting may be the lifting of a portion of the sealingtape 224 when the edge of the sealingtape 224 is caught by clothing or other objects. -
FIG. 11 is a plan view of a sealingtape 324 illustrating additional details that may be associated with some embodiments. The sealingtape 324 may be similar to and operate in a manner similar to the sealingtape 124 ofFIG. 9 . Similar elements have been indexed to 300. For example, the sealingtape 324 may have awidth 360, alength 362, a layer of abonding adhesive 328, a layer of a sealing adhesive 330, andapertures 334. In some embodiments, theapertures 134 may have a diameter between about 10 mm and about 15 mm. In other embodiments, theapertures 334 may have a diameter between about 5 mm and about 30 mm. In some embodiments, the sealingtape 324 may include a single row ofapertures 334. In some embodiments, the apertures are disposed near a center of thewidth 360 of the sealingtape 334 and may be evenly distributed parallel to thelength 362 of the sealingtape 334. -
FIG. 12 is a plan view of a sealingtape 424 illustrating additional details that may be associated with some embodiments. The sealingtape 424 may be similar to and operate in a manner similar to the sealingtape 224 ofFIG. 10 . Similar elements have been indexed to 400. For example, the sealingtape 424 may have awidth 460, alength 462, a layer of abonding adhesive 428, a layer of a sealing adhesive 430, andapertures 435. Theapertures 435 may be positioned similar to theapertures 235 and have a radius equal to a radius of theapertures 334. -
FIG. 13 is a plan view of a sealingtape 524 illustrating additional details that may be associated with some embodiments. The sealingtape 524 may be similar to and operate in a manner similar to the sealingtape 124 ofFIG. 9 . Similar elements have been indexed to 500. For example, the sealingtape 524 may have awidth 560, alength 562, a strip of abonding adhesive 528, and a strip of a sealingadhesive 530. In some embodiments, the sealingtape 524 may include two strips of the sealing adhesive 530 disposed adjacent to an edge of the sealingtape 524. The two strips of the sealing adhesive 530 may be parallel to thelength 562. In some embodiments, the two strips of the sealing adhesive 530 may each have awidth 564. In some embodiments, thewidth 564 of each strip of the sealing adhesive 530 may be between about 5 mm and about 7 mm. In some embodiments, awidth 566 of thebonding adhesive 528 exposed through the sealing adhesive 530 may be between about 6 mm and about 10 mm. -
FIG. 14 is a plan view of a sealingtape 624 illustrating additional details that may be associated with some embodiments. The sealingtape 624 may be similar to and operate in a manner similar to the sealingtape 524 ofFIG. 13 . Similar elements have been indexed to 600. For example, the sealingtape 624 may have awidth 660, alength 662, one or more strips of abonding adhesive 628, and one or more strips of a sealingadhesive 630. In some embodiments, the sealingtape 624 may include two strips of the sealingadhesive 630. In some embodiments, afirst strip 631 of the sealing adhesive 630 may be disposed adjacent to an edge of the sealingtape 624. Asecond strip 633 of the sealing adhesive 630 may be disposed between the edges of the sealingtape 624. Thefirst strip 631 and thesecond strip 633 of the sealing adhesive 630 may be parallel to thelength 662. In some embodiments, thefirst strip 631 and thesecond strip 633 of the sealing adhesive 630 may each have awidth 664. In some embodiments, thewidth 664 may be between about 5 mm and about 7 mm. In some embodiments, the portion of thebonding adhesive 628 exposed through the sealing adhesive 630 may include afirst strip 627 and asecond strip 629. Thefirst strip 627 may be disposed between thefirst strip 631 and thesecond strip 633 of the sealingadhesive 630. Thesecond strip 629 may be disposed adjacent to an edge of the sealingtape 624 opposite thefirst strip 631. In some embodiments, awidth 666 of each of thefirst strip 627 and thesecond strip 629 of thebonding adhesive 628 exposed through the sealing adhesive 630 may be between about 3 mm and about 5 mm. In some embodiments, the sealingtape 624 may be applied so that thesecond strip 629 of thebonding adhesive 628 may be in contact with theepidermis 116 to formbonding couplings 136 with the epidermis. Thefirst strip 627 of thebonding adhesive 628 may be in contact with thedrape 108 to formbonding couplings 136 with thedrape 108. -
FIG. 15 is a plan view of a sealingtape 724 illustrating additional details that may be associated with some embodiments. The sealingtape 724 may be similar to and operate in a manner similar to the sealingtape 124 ofFIG. 9 . Similar elements have been indexed to 700. For example, the sealingtape 724 may have awidth 760, alength 762, abonding adhesive 728, and a sealingadhesive 730. In some embodiments, the sealing adhesive 730 may trace a path between opposite edges of the sealingtape 724. The sealing adhesive 730 may propagate parallel to thelength 762. For example, the sealing adhesive 730 may have a pattern similar to a wave. In some embodiments, the sealing adhesive 730 may have a regular wave pattern with a repeating slope between each edge of the sealingtape 724. In some embodiments, the sealing adhesive 730 may have awidth 768. In some embodiments, thewidth 768 may be between about 5 mm and about 7 mm. - Any of the above patterns may be manufacturing by layering the adhesives as described above with respect to
FIG. 3 ,FIG. 4A , andFIG. 4B or by registering the adhesives as described above with respect toFIG. 5 ,FIG. 6 ,FIG. 7 , andFIG. 8 . - In some embodiments, the adhesives may be mixed with blowing or expanding agents, for example organic and inorganic low temperature boiling point liquids. The blowing or expanding agents allow for the adhesives to expand under the application of heat or light to increase the thickness of the adhesive following deposition by one of the above described processes. The blowing or expanding agents may reduce the amount of adhesive needed and decrease the cost of production and the cost of the resulting sealing
tape 124. In some embodiments, the application of heat or light may be delayed until application of the sealingtape 124 to theepidermis 116 so that the contact area with the patient'sepidermis 116 may increase as thebonding adhesive 128 and the sealing adhesive 130 warm by contact with the patient'sepidermis 116. The application of light or heat following application of the sealingtape 124 to theepidermis 116 can provide a better seal for some embodiments of the sealingtape 124 to theepidermis 116. - In testing performed with sealing tape in accordance with the embodiments described herein, leaks between a standard drape and a textured surface were reduced. A drape was disposed over the textured surface to create a sealed space. The drape was fluidly coupled to a negative-pressure source. The negative-pressure source was operated and a pressure was measured in the sealed space. When the pressure was measured, the negative-pressure source was unable to achieve 125 mm Hg negative pressure. A leak of about 2 L/m was determined to exist between the standard drape and the textured surface.
- Sealing tape in accordance with the embodiments described herein were applied to the edges of the drape. The negative-pressure source was again operated and the pressure measured in the sealed space. By using the sealing tape, the negative-pressure source was able to achieve the therapy pressure of 125 mm Hg and the leak was reduced to 0.08 L/m. The textured surface was then heated, further reducing the leak to 0.01 L/m.
- Sealing tape in accordance with the embodiments described herein were also disposed directly on the texture surface. The standard drape was disposed over the textured surface and coupled to the sealing tape to create the sealed space. The textured surface was heated to mimic a patient's body heat. The standard drape was fluidly coupled to the negative-pressure source. The negative-pressure source was operated and a pressure was measured in the sealed space. The negative-pressure source was able to achieve 125 mm Hg negative pressure and the leak was reduced to 0.003 L/m.
- The sealing tape may provide a lower cost solution to improving the sealing of standard drapes. The sealing tape may be added to current dressings with low disruption to production or use. The sealing tape also provide a step-change improvement in sealing with a pre-applied dressing using existing materials prior to release from a facility. The sealing tape may also later be used under a drape on re-application of the dressing to provide a seal to a tissue site. The sealing tape may also provide an increased efficiency of adhesive usage as less silicone adhesive may be needed to retain the silicone adhesive in place and under compression with the acrylic adhesive.
- Although illustrative, non-limiting embodiments have been disclosed, it should be understood that various changes, substitutions, permutations, and alterations can be made without departing from the scope of the appended claims. It will be appreciated that features that may be described in connection to one embodiment may also be applicable to other embodiments. It will also be understood that the benefits and advantages described above may relate to one embodiment or may relate to several embodiments. It will further be understood that reference to “an” item refers to one or more of those items.
- The steps of the methods described herein may be carried out in a suitable order, or simultaneously where appropriate.
- Where appropriate, aspects of the embodiments described above may be combined with aspects of the other embodiments described to form further examples having comparable or different properties and addressing the same or different problems.
- It will be understood that the embodiments described herein are given by way of example only and that various modifications may be made by those skilled in the art. The above specification, examples and data provide a complete description of the structure and use of exemplary embodiments. Although various embodiments have been described above with a certain degree of particularity, or with reference to one or more individual illustrations, those skilled in the art could make numerous alterations to the example embodiments without departing from the scope of the claims.
Claims (23)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/287,862 US20190192750A1 (en) | 2013-10-28 | 2019-02-27 | Hybrid Sealing Tape |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361896582P | 2013-10-28 | 2013-10-28 | |
US14/517,521 US10946124B2 (en) | 2013-10-28 | 2014-10-17 | Hybrid sealing tape |
US16/287,862 US20190192750A1 (en) | 2013-10-28 | 2019-02-27 | Hybrid Sealing Tape |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/517,521 Division US10946124B2 (en) | 2013-10-28 | 2014-10-17 | Hybrid sealing tape |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190192750A1 true US20190192750A1 (en) | 2019-06-27 |
Family
ID=51869030
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/517,521 Active 2036-05-30 US10946124B2 (en) | 2013-10-28 | 2014-10-17 | Hybrid sealing tape |
US16/287,862 Abandoned US20190192750A1 (en) | 2013-10-28 | 2019-02-27 | Hybrid Sealing Tape |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/517,521 Active 2036-05-30 US10946124B2 (en) | 2013-10-28 | 2014-10-17 | Hybrid sealing tape |
Country Status (3)
Country | Link |
---|---|
US (2) | US10946124B2 (en) |
EP (2) | EP3062753B1 (en) |
WO (1) | WO2015065742A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111579144A (en) * | 2020-04-08 | 2020-08-25 | 中国海洋大学 | Synchronous measurement device and method for double-dispersion interface pressure in emulsion and application |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2715843A1 (en) | 2008-03-05 | 2009-09-11 | Kci Licensing Inc. | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
GB0808376D0 (en) | 2008-05-08 | 2008-06-18 | Bristol Myers Squibb Co | Wound dressing |
GB0817796D0 (en) | 2008-09-29 | 2008-11-05 | Convatec Inc | wound dressing |
US8814842B2 (en) | 2010-03-16 | 2014-08-26 | Kci Licensing, Inc. | Delivery-and-fluid-storage bridges for use with reduced-pressure systems |
GB201020236D0 (en) | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
US9526816B2 (en) | 2010-12-08 | 2016-12-27 | Convatec Technologies Inc. | Wound exudate monitor accessory |
EP2648793B1 (en) | 2010-12-08 | 2020-03-11 | ConvaTec Technologies Inc. | Integrated system for assessing wound exudates |
EP2723286B2 (en) | 2011-06-24 | 2021-10-13 | KCI Licensing, Inc. | Reduced-pressure dressings employing tissue-fixation elements |
GB201115182D0 (en) | 2011-09-02 | 2011-10-19 | Trio Healthcare Ltd | Skin contact material |
GB2497406A (en) | 2011-11-29 | 2013-06-12 | Webtec Converting Llc | Dressing with a perforated binder layer |
GB201120693D0 (en) | 2011-12-01 | 2012-01-11 | Convatec Technologies Inc | Wound dressing for use in vacuum therapy |
US10940047B2 (en) | 2011-12-16 | 2021-03-09 | Kci Licensing, Inc. | Sealing systems and methods employing a hybrid switchable drape |
EP3005997A1 (en) | 2011-12-16 | 2016-04-13 | KCI Licensing, Inc. | Releasable medical drapes |
EP3092990B1 (en) | 2012-11-16 | 2020-03-11 | KCI Licensing, Inc. | Method of manufacturing a medical drape with pattern adhesive layers |
JP2016507663A (en) | 2012-12-20 | 2016-03-10 | コンバテック・テクノロジーズ・インコーポレイテッドConvatec Technologies Inc | Processing of chemically modified cellulosic fibers |
AU2014342903B2 (en) | 2013-10-30 | 2018-09-20 | Solventum Intellectual Properties Company | Dressing with differentially sized perforations |
US10398814B2 (en) | 2013-10-30 | 2019-09-03 | Kci Licensing, Inc. | Condensate absorbing and dissipating system |
WO2015065616A1 (en) | 2013-10-30 | 2015-05-07 | Kci Licensing, Inc. | Dressing with sealing and retention intereface |
EP3527237B1 (en) | 2013-10-30 | 2020-09-09 | KCI Licensing, Inc. | Absorbent conduit and system |
US11026844B2 (en) | 2014-03-03 | 2021-06-08 | Kci Licensing, Inc. | Low profile flexible pressure transmission conduit |
JP6743050B2 (en) | 2015-04-27 | 2020-08-19 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Pressure reducing device and method |
WO2016182977A1 (en) | 2015-05-08 | 2016-11-17 | Kci Licensing, Inc. | Low acuity dressing with integral pump |
US20210239215A1 (en) * | 2015-07-17 | 2021-08-05 | The Patent Well LLC | Tacky polyurethane composites |
EP3344205B1 (en) | 2015-09-01 | 2020-09-30 | KCI Licensing, Inc. | Dressing with increased apposition force |
EP3349807B1 (en) | 2015-09-17 | 2021-02-24 | 3M Innovative Properties Company | Hybrid silicone and acrylic adhesive cover for use with wound treatment |
EP3377014A1 (en) | 2015-11-18 | 2018-09-26 | KCI Licensing, Inc. | Medical drapes and methods for reducing trauma on removal |
JP6995765B2 (en) * | 2016-03-01 | 2022-01-17 | スリーエム イノベイティブ プロパティズ カンパニー | Drape used with medical treatment systems |
CA3016484A1 (en) | 2016-03-07 | 2017-09-14 | Smith & Nephew Plc | Wound treatment apparatuses and methods with negative pressure source integrated into wound dressing |
KR20170115124A (en) | 2016-04-04 | 2017-10-17 | 엘지디스플레이 주식회사 | Sound generation actuator of panel vibration type and double faced display device with the same |
US10129646B2 (en) | 2016-03-28 | 2018-11-13 | Lg Display Co., Ltd. | Panel vibration type sound generating display device |
KR101704517B1 (en) | 2016-03-28 | 2017-02-09 | 엘지디스플레이 주식회사 | Display device for generating sound by panel vibration type |
KR20170114471A (en) | 2016-04-05 | 2017-10-16 | 엘지디스플레이 주식회사 | Organic light emitting display device |
ES2904480T3 (en) | 2016-03-30 | 2022-04-05 | Convatec Technologies Inc | Detection of microbial infections in wounds |
KR20190015210A (en) | 2016-03-30 | 2019-02-13 | 퀄리자임 다이아그노스틱스 게엠베하 엔드 코 카게 | Detection of microbial infection in wound |
WO2017186771A1 (en) | 2016-04-26 | 2017-11-02 | Smith & Nephew Plc | Wound dressings and methods of use with integrated negative pressure source having a fluid ingress inhibition component |
CN109069711A (en) | 2016-05-03 | 2018-12-21 | 史密夫及内修公开有限公司 | System and method for driving negative pressure source in negative pressure treatment system |
CN109069710B (en) | 2016-05-03 | 2022-04-12 | 史密夫及内修公开有限公司 | Optimizing power delivery to a negative pressure source in a negative pressure therapy system |
US11096831B2 (en) | 2016-05-03 | 2021-08-24 | Smith & Nephew Plc | Negative pressure wound therapy device activation and control |
AU2017292028B2 (en) | 2016-07-08 | 2023-03-02 | Convatec Technologies Inc. | Fluid flow sensing |
CN109688991B (en) | 2016-07-08 | 2021-10-29 | 康沃特克科技公司 | Flexible negative pressure system |
AU2017292876B2 (en) | 2016-07-08 | 2022-01-20 | Convatec Technologies Inc. | Fluid collection apparatus |
AU2017315129B2 (en) | 2016-08-25 | 2022-10-27 | Smith & Nephew Plc | Absorbent negative pressure wound therapy dressing |
AU2017336310B2 (en) | 2016-09-30 | 2022-12-08 | Smith & Nephew Plc | Negative pressure wound treatment apparatuses and methods with integrated electronics |
CN106420167B (en) * | 2016-10-18 | 2022-05-24 | 广东美捷威通生物科技有限公司 | Vacuum lock liquid treatment system |
EP3741336A1 (en) * | 2016-10-26 | 2020-11-25 | 3M Innovative Properties Company | Hybrid drape |
CN110582257B (en) | 2017-03-08 | 2022-03-15 | 史密夫及内修公开有限公司 | Negative pressure wound therapy device control in the presence of fault conditions |
WO2018163093A1 (en) * | 2017-03-09 | 2018-09-13 | Secretary, Department Of Biotechnology | A wound dressing for combined negative pressure and fluid delivery system |
CN110612131B (en) | 2017-05-09 | 2023-05-16 | 史密夫及内修公开有限公司 | Redundant control for negative pressure wound therapy system |
EP3681550B1 (en) | 2017-09-13 | 2023-11-08 | Smith & Nephew PLC | Negative pressure wound treatment apparatuses |
GB201718070D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Negative pressure wound treatment apparatuses and methods with integrated electronics |
WO2019086332A1 (en) | 2017-11-01 | 2019-05-09 | Smith & Nephew Plc | Negative pressure wound treatment apparatuses and methods with integrated electronics |
GB201718054D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Sterilization of integrated negative pressure wound treatment apparatuses and sterilization methods |
GB201718072D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Negative pressure wound treatment apparatuses and methods with integrated electronics |
USD898925S1 (en) | 2018-09-13 | 2020-10-13 | Smith & Nephew Plc | Medical dressing |
CN114144209A (en) * | 2019-06-20 | 2022-03-04 | 凯希特许有限公司 | Systems, devices, and methods for negative pressure therapy with reduced tissue ingrowth and extended wear time |
US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
US20210337901A1 (en) * | 2020-04-30 | 2021-11-04 | Daniel William Jette | Attachable, removable, and disposable sweatband strip |
Family Cites Families (500)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3172808A (en) | 1965-03-09 | Method of treating wounds | ||
US1355846A (en) | 1920-02-06 | 1920-10-19 | David A Rannells | Medical appliance |
US1944834A (en) | 1932-01-16 | 1934-01-23 | Johnson & Johnson | Adhesive tape or plaster |
US2552664A (en) | 1947-04-24 | 1951-05-15 | Bertha W Burdine | Adhesive material |
US2547758A (en) | 1949-01-05 | 1951-04-03 | Wilmer B Keeling | Instrument for treating the male urethra |
US2632443A (en) | 1949-04-18 | 1953-03-24 | Eleanor P Lesher | Surgical dressing |
GB692578A (en) | 1949-09-13 | 1953-06-10 | Minnesota Mining & Mfg | Improvements in or relating to drape sheets for surgical use |
US2682873A (en) | 1952-07-30 | 1954-07-06 | Johnson & Johnson | General purpose protective dressing |
NL189176B (en) | 1956-07-13 | 1900-01-01 | Hisamitsu Pharmaceutical Co | PLASTER BASED ON A SYNTHETIC RUBBER. |
US2860081A (en) | 1954-11-22 | 1958-11-11 | Bert M Eiken | Trouser cuff tack |
US2969057A (en) | 1957-11-04 | 1961-01-24 | Brady Co W H | Nematodic swab |
US3183116A (en) | 1960-03-14 | 1965-05-11 | Kendall & Co | Method of making perforated adhesive tapes |
US3066672A (en) | 1960-09-27 | 1962-12-04 | Jr William H Crosby | Method and apparatus for serial sampling of intestinal juice |
GB1052614A (en) | 1964-06-04 | |||
US3367332A (en) | 1965-08-27 | 1968-02-06 | Gen Electric | Product and process for establishing a sterile area of skin |
US3520300A (en) | 1967-03-15 | 1970-07-14 | Amp Inc | Surgical sponge and suction device |
US3777016A (en) | 1967-10-31 | 1973-12-04 | J Gilbert | Composition and method for the treat-ment of damaged skin |
US3568675A (en) | 1968-08-30 | 1971-03-09 | Clyde B Harvey | Fistula and penetrating wound dressing |
US4141361A (en) | 1970-02-09 | 1979-02-27 | Snyder Manufacturing Co., Incorporated | Evacuator |
US3682180A (en) | 1970-06-08 | 1972-08-08 | Coilform Co Inc | Drain clip for surgical drain |
BE789293Q (en) | 1970-12-07 | 1973-01-15 | Parke Davis & Co | MEDICO-SURGICAL DRESSING FOR BURNS AND SIMILAR LESIONS |
US3742952A (en) | 1971-04-28 | 1973-07-03 | Alpha Ind Inc | Surgical suction pump assembly |
US3779243A (en) | 1971-10-15 | 1973-12-18 | J Tussey | Contamination free surgical evacuator |
GB1386800A (en) | 1971-10-27 | 1975-03-12 | Johnson & Johnson | Self-adhesive disposable surgical drape |
US3852823A (en) | 1972-03-08 | 1974-12-10 | J Jones | Method of sealing a bathing or shower cap to the head of the wearer |
US3774611A (en) | 1972-06-08 | 1973-11-27 | J Tussey | Stabilized contamination free surgical evacuator |
US3983297A (en) | 1972-06-14 | 1976-09-28 | Teijin Limited | Pressure-sensitive adhesive tape or drape |
US3826254A (en) | 1973-02-26 | 1974-07-30 | Verco Ind | Needle or catheter retaining appliance |
US3903882A (en) | 1974-04-19 | 1975-09-09 | American Cyanamid Co | Composite dressing |
US3967624A (en) | 1975-04-04 | 1976-07-06 | Johnson & Johnson | Disposable diaper with tab fasteners having a perforated cover strip |
DE2527706A1 (en) | 1975-06-21 | 1976-12-30 | Hanfried Dr Med Weigand | DEVICE FOR THE INTRODUCTION OF CONTRAST AGENTS INTO AN ARTIFICIAL INTESTINAL OUTLET |
US4060081A (en) | 1975-07-15 | 1977-11-29 | Massachusetts Institute Of Technology | Multilayer membrane useful as synthetic skin |
GB1563695A (en) | 1975-07-29 | 1980-03-26 | Smith & Nephew Res | Adhesive material |
DE2640413C3 (en) | 1976-09-08 | 1980-03-27 | Richard Wolf Gmbh, 7134 Knittlingen | Catheter monitor |
NL7710909A (en) | 1976-10-08 | 1978-04-11 | Smith & Nephew | COMPOSITE STRAPS. |
GB1562244A (en) | 1976-11-11 | 1980-03-05 | Lock P M | Wound dressing materials |
US4080970A (en) | 1976-11-17 | 1978-03-28 | Miller Thomas J | Post-operative combination dressing and internal drain tube with external shield and tube connector |
US4139004A (en) | 1977-02-17 | 1979-02-13 | Gonzalez Jr Harry | Bandage apparatus for treating burns |
US4184510A (en) | 1977-03-15 | 1980-01-22 | Fibra-Sonics, Inc. | Valued device for controlling vacuum in surgery |
US4165748A (en) | 1977-11-07 | 1979-08-28 | Johnson Melissa C | Catheter tube holder |
US4174664A (en) | 1978-05-08 | 1979-11-20 | Milliken Research Corporation | Cylindrical screen having aperatures with geometric centers defined by arrays of equilateral triangles |
US4256109A (en) | 1978-07-10 | 1981-03-17 | Nichols Robert L | Shut off valve for medical suction apparatus |
SE414994B (en) | 1978-11-28 | 1980-09-01 | Landstingens Inkopscentral | VENKATETERFORBAND |
DE2953373A1 (en) | 1978-12-06 | 1981-01-08 | P Svedman | Device for treating tissues,for example skin |
US4266545A (en) | 1979-04-06 | 1981-05-12 | Moss James P | Portable suction device for collecting fluids from a closed wound |
US4284079A (en) | 1979-06-28 | 1981-08-18 | Adair Edwin Lloyd | Method for applying a male incontinence device |
US4261363A (en) | 1979-11-09 | 1981-04-14 | C. R. Bard, Inc. | Retention clips for body fluid drains |
US4569348A (en) | 1980-02-22 | 1986-02-11 | Velcro Usa Inc. | Catheter tube holder strap |
US4480638A (en) | 1980-03-11 | 1984-11-06 | Eduard Schmid | Cushion for holding an element of grafted skin |
US4323069A (en) | 1980-05-12 | 1982-04-06 | The Procter & Gamble Company | Disposable absorbent article having an intermediate layer interposed between the topsheet and the absorbent core |
US5445604A (en) | 1980-05-22 | 1995-08-29 | Smith & Nephew Associated Companies, Ltd. | Wound dressing with conformable elastomeric wound contact layer |
US4297995A (en) | 1980-06-03 | 1981-11-03 | Key Pharmaceuticals, Inc. | Bandage containing attachment post |
US4529402A (en) | 1980-07-08 | 1985-07-16 | Snyder Laboratories, Inc. | Closed wound suction evacuator with rotary valve |
NZ197782A (en) | 1980-07-30 | 1985-07-31 | Smith & Nephew Ass | A moisture vapour transmitting elastic bandage |
US4333468A (en) | 1980-08-18 | 1982-06-08 | Geist Robert W | Mesentery tube holder apparatus |
US4343848A (en) | 1980-12-15 | 1982-08-10 | Ethyl Corporation | Embossed thermoplastic material |
US4995382A (en) | 1981-02-13 | 1991-02-26 | Smith And Nephew Associated Companies Limited | Wound dressing, manufacture and use |
US4465485A (en) | 1981-03-06 | 1984-08-14 | Becton, Dickinson And Company | Suction canister with unitary shut-off valve and filter features |
US4392853A (en) | 1981-03-16 | 1983-07-12 | Rudolph Muto | Sterile assembly for protecting and fastening an indwelling device |
JPS57156403A (en) | 1981-03-24 | 1982-09-27 | Shin Etsu Chem Co Ltd | Gradual vapor releaser with good shaping property |
US4360015A (en) | 1981-05-14 | 1982-11-23 | Hartford Corporation | Multilayer absorbent structure |
US4373519A (en) | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4392858A (en) | 1981-07-16 | 1983-07-12 | Sherwood Medical Company | Wound drainage device |
US4419097A (en) | 1981-07-31 | 1983-12-06 | Rexar Industries, Inc. | Attachment for catheter tube |
SE429197B (en) | 1981-10-14 | 1983-08-22 | Frese Nielsen | SAR TREATMENT DEVICE |
DE3146266A1 (en) | 1981-11-21 | 1983-06-01 | B. Braun Melsungen Ag, 3508 Melsungen | COMBINED DEVICE FOR A MEDICAL SUCTION DRAINAGE |
US4551139A (en) | 1982-02-08 | 1985-11-05 | Marion Laboratories, Inc. | Method and apparatus for burn wound treatment |
US4475909A (en) | 1982-05-06 | 1984-10-09 | Eisenberg Melvin I | Male urinary device and method for applying the device |
EP0097517B1 (en) | 1982-06-22 | 1987-06-24 | Smith and Nephew Associated Companies p.l.c. | Wound dressing, manufacture and use |
EP0100148B1 (en) | 1982-07-06 | 1986-01-08 | Dow Corning Limited | Medical-surgical dressing and a process for the production thereof |
NZ206837A (en) | 1983-01-27 | 1986-08-08 | Johnson & Johnson Prod Inc | Thin film adhesive dressing:backing material in three sections |
US4548202A (en) | 1983-06-20 | 1985-10-22 | Ethicon, Inc. | Mesh tissue fasteners |
US4540412A (en) | 1983-07-14 | 1985-09-10 | The Kendall Company | Device for moist heat therapy |
US4543100A (en) | 1983-11-01 | 1985-09-24 | Brodsky Stuart A | Catheter and drain tube retainer |
DE3340530A1 (en) | 1983-11-09 | 1985-05-15 | Rauscher & Co Verbandstoff- und Wattefabriken, Wien | SUCTIONABLE Wound Dressing And Method Of Making It |
GB8334484D0 (en) | 1983-12-24 | 1984-02-01 | Smith & Nephew Ass | Surgical dressing |
US4525374A (en) | 1984-02-27 | 1985-06-25 | Manresa, Inc. | Treating hydrophobic filters to render them hydrophilic |
GB2157958A (en) | 1984-05-03 | 1985-11-06 | Ernest Edward Austen Bedding | Ball game net support |
US4897081A (en) | 1984-05-25 | 1990-01-30 | Thermedics Inc. | Percutaneous access device |
US5215522A (en) | 1984-07-23 | 1993-06-01 | Ballard Medical Products | Single use medical aspirating device and method |
GB8419745D0 (en) | 1984-08-02 | 1984-09-05 | Smith & Nephew Ass | Wound dressing |
US4872450A (en) | 1984-08-17 | 1989-10-10 | Austad Eric D | Wound dressing and method of forming same |
US4826494A (en) | 1984-11-09 | 1989-05-02 | Stryker Corporation | Vacuum wound drainage system |
US4655754A (en) | 1984-11-09 | 1987-04-07 | Stryker Corporation | Vacuum wound drainage system and lipids baffle therefor |
US4605399A (en) | 1984-12-04 | 1986-08-12 | Complex, Inc. | Transdermal infusion device |
US4664652A (en) | 1985-02-07 | 1987-05-12 | Snyder Laboratories, Inc. | Wound evacuator |
GB8509977D0 (en) | 1985-04-18 | 1985-05-30 | Juhasz L | Wound dressings |
US5037397A (en) | 1985-05-03 | 1991-08-06 | Medical Distributors, Inc. | Universal clamp |
GB2176401A (en) | 1985-06-12 | 1986-12-31 | Vernon Carus Ltd | Wound dressing |
US4640688A (en) | 1985-08-23 | 1987-02-03 | Mentor Corporation | Urine collection catheter |
US4710165A (en) | 1985-09-16 | 1987-12-01 | Mcneil Charles B | Wearable, variable rate suction/collection device |
US4758220A (en) | 1985-09-26 | 1988-07-19 | Alcon Laboratories, Inc. | Surgical cassette proximity sensing and latching apparatus |
US4871611A (en) | 1985-11-15 | 1989-10-03 | Mead Release Products, Inc. | Breathable backing or release liner and process for forming the same |
US4733659A (en) | 1986-01-17 | 1988-03-29 | Seton Company | Foam bandage |
WO1987004626A1 (en) | 1986-01-31 | 1987-08-13 | Osmond, Roger, L., W. | Suction system for wound and gastro-intestinal drainage |
JPS62139523U (en) | 1986-02-14 | 1987-09-03 | ||
US4838883A (en) | 1986-03-07 | 1989-06-13 | Nissho Corporation | Urine-collecting device |
GB2192142B (en) | 1986-07-04 | 1990-11-28 | Johnson & Johnson | Wound dressing |
EP0241838B1 (en) | 1986-04-07 | 1992-04-15 | Agency Of Industrial Science And Technology | Antithrombogenic material |
JPS62275456A (en) | 1986-05-22 | 1987-11-30 | 帝三製薬株式会社 | Wound protective material |
EP0247571B1 (en) | 1986-05-28 | 1991-08-28 | LTS Lohmann Therapie-Systeme GmbH & Co. KG | System for anchoring catheters, tubes or the like onto the skin |
JPS62281965A (en) | 1986-05-29 | 1987-12-07 | テルモ株式会社 | Catheter and catheter fixing member |
US5025783A (en) | 1986-09-02 | 1991-06-25 | Sparta Surgical Corp. | Method of applying a medical dressing device |
GB8621884D0 (en) | 1986-09-11 | 1986-10-15 | Bard Ltd | Catheter applicator |
GB2195255B (en) | 1986-09-30 | 1991-05-01 | Vacutec Uk Limited | Apparatus for vacuum treatment of an epidermal surface |
US4743232A (en) | 1986-10-06 | 1988-05-10 | The Clinipad Corporation | Package assembly for plastic film bandage |
DE3634569A1 (en) | 1986-10-10 | 1988-04-21 | Sachse Hans E | CONDOM CATHETER, A URINE TUBE CATHETER FOR PREVENTING RISING INFECTIONS |
NL8602662A (en) | 1986-10-23 | 1988-05-16 | Patentico Ltd | COVER PLATE TO BE ADAPTED. |
JPS63135179A (en) | 1986-11-26 | 1988-06-07 | 立花 俊郎 | Subcataneous drug administration set |
GB8628564D0 (en) | 1986-11-28 | 1987-01-07 | Smiths Industries Plc | Anti-foaming agent suction apparatus |
US4867150A (en) | 1987-01-20 | 1989-09-19 | The B. F. Goodrich Company | Perforated elastomeric soft film and wound dressing made therewith |
CN87101823B (en) | 1987-03-12 | 1988-10-05 | 铁汉 | Medical dressing materials without adhesion |
GB8706116D0 (en) | 1987-03-14 | 1987-04-15 | Smith & Nephew Ass | Adhesive dressings |
US4787888A (en) | 1987-06-01 | 1988-11-29 | University Of Connecticut | Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a) |
US5356386A (en) | 1987-06-05 | 1994-10-18 | Uresil Corporation | Apparatus for locating body cavities |
US4863449A (en) | 1987-07-06 | 1989-09-05 | Hollister Incorporated | Adhesive-lined elastic condom cathether |
US4930997A (en) | 1987-08-19 | 1990-06-05 | Bennett Alan N | Portable medical suction device |
US5176663A (en) | 1987-12-02 | 1993-01-05 | Pal Svedman | Dressing having pad with compressibility limiting elements |
US5018515A (en) | 1987-12-14 | 1991-05-28 | The Kendall Company | See through absorbent dressing |
US4906240A (en) | 1988-02-01 | 1990-03-06 | Matrix Medica, Inc. | Adhesive-faced porous absorbent sheet and method of making same |
US4832008A (en) | 1988-02-09 | 1989-05-23 | The Kendall Company | Wound dressing with release sheets strip |
US4981474A (en) | 1988-02-16 | 1991-01-01 | Baxter Travenol Laboratories, Inc. | Body fluid drainage device |
US4985019A (en) | 1988-03-11 | 1991-01-15 | Michelson Gary K | X-ray marker |
GB8812096D0 (en) | 1988-05-21 | 1988-06-22 | Smith & Nephew Ass | Adhesive sheet |
GB8812803D0 (en) | 1988-05-28 | 1988-06-29 | Smiths Industries Plc | Medico-surgical containers |
US5374261A (en) | 1990-07-24 | 1994-12-20 | Yoon; Inbae | Multifunctional devices for use in endoscopic surgical procedures and methods-therefor |
US4919654A (en) | 1988-08-03 | 1990-04-24 | Kalt Medical Corporation | IV clamp with membrane |
US5000741A (en) | 1988-08-22 | 1991-03-19 | Kalt Medical Corporation | Transparent tracheostomy tube dressing |
JPH046760Y2 (en) | 1988-12-27 | 1992-02-24 | ||
EP0379416B1 (en) | 1989-01-16 | 1995-03-08 | Roussel-Uclaf | Azabicycloheptene derivatives and their salts, process for their preparation, their use as medicaments and compositions containing them |
US5127601A (en) | 1989-01-23 | 1992-07-07 | Lightning Diversion Systems | Conformal lightning shield and method of making |
GB8906100D0 (en) | 1989-03-16 | 1989-04-26 | Smith & Nephew | Laminates |
US5100396A (en) | 1989-04-03 | 1992-03-31 | Zamierowski David S | Fluidic connection system and method |
US5527293A (en) | 1989-04-03 | 1996-06-18 | Kinetic Concepts, Inc. | Fastening system and method |
US4969880A (en) | 1989-04-03 | 1990-11-13 | Zamierowski David S | Wound dressing and treatment method |
US5261893A (en) | 1989-04-03 | 1993-11-16 | Zamierowski David S | Fastening system and method |
US5266372A (en) | 1989-04-24 | 1993-11-30 | Nitto Denko Corporation | Fixing tape |
US5358494A (en) | 1989-07-11 | 1994-10-25 | Svedman Paul | Irrigation dressing |
JP2719671B2 (en) | 1989-07-11 | 1998-02-25 | 日本ゼオン株式会社 | Wound dressing |
US5232453A (en) | 1989-07-14 | 1993-08-03 | E. R. Squibb & Sons, Inc. | Catheter holder |
GB2235877A (en) | 1989-09-18 | 1991-03-20 | Antonio Talluri | Closed wound suction apparatus |
US5152757A (en) | 1989-12-14 | 1992-10-06 | Brigham And Women's Hospital | System for diagnosis and treatment of wounds |
US5423778A (en) | 1989-12-14 | 1995-06-13 | Elof Eriksson | System and method for transplantation of cells |
US5270358A (en) | 1989-12-28 | 1993-12-14 | Minnesota Mining And Manufacturing Company | Composite of a disperesed gel in an adhesive matrix |
US6680113B1 (en) | 1989-12-29 | 2004-01-20 | 3M Innovative Properties Company | Multi-layered dressing |
US5112323A (en) | 1990-02-08 | 1992-05-12 | Snyder Laboratories, Inc. | Wound evacuator |
US5134994A (en) | 1990-02-12 | 1992-08-04 | Say Sam L | Field aspirator in a soft pack with externally mounted container |
US4996128A (en) | 1990-03-12 | 1991-02-26 | Nova Manufacturing, Inc. | Rechargeable battery |
US5092858A (en) | 1990-03-20 | 1992-03-03 | Becton, Dickinson And Company | Liquid gelling agent distributor device |
US5092323A (en) | 1990-06-29 | 1992-03-03 | Hollister Incorporated | Moisture-absorbing, site-revealing adhesive dressing |
JP2941918B2 (en) | 1990-09-19 | 1999-08-30 | テルモ株式会社 | Weighing device |
US5151314A (en) | 1991-01-31 | 1992-09-29 | Johnson & Johnson Medical, Inc. | Three-layer laminated panel |
AU641580B2 (en) | 1991-02-28 | 1993-09-23 | National Starch And Chemical Investment Holding Corporation | Water vapor permeable pressure sensitive adhesive composition |
US5180375A (en) | 1991-05-02 | 1993-01-19 | Feibus Miriam H | Woven surgical drain and woven surgical sponge |
US5149331A (en) | 1991-05-03 | 1992-09-22 | Ariel Ferdman | Method and device for wound closure |
US5653224A (en) | 1991-06-10 | 1997-08-05 | Creative Integration & Design, Inc. | Nasal dilator with areas of adhesive engagement of varying strength |
CA2071391C (en) | 1991-07-29 | 1998-05-05 | Thomas H. Gilman | Vented wound dressing |
US5387207A (en) | 1991-08-12 | 1995-02-07 | The Procter & Gamble Company | Thin-unit-wet absorbent foam materials for aqueous body fluids and process for making same |
SE502780C2 (en) | 1991-09-25 | 1996-01-08 | Siemens Elema Ab | dehumidifying device |
US5342329A (en) | 1991-10-11 | 1994-08-30 | Inmed Ltda. | Portable disposable device for post-surgical suction |
US5278100A (en) | 1991-11-08 | 1994-01-11 | Micron Technology, Inc. | Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers |
US5636643A (en) | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5645081A (en) | 1991-11-14 | 1997-07-08 | Wake Forest University | Method of treating tissue damage and apparatus for same |
US5279550A (en) | 1991-12-19 | 1994-01-18 | Gish Biomedical, Inc. | Orthopedic autotransfusion system |
US5585178A (en) * | 1991-12-31 | 1996-12-17 | Minnesota Mining & Manufacturing Company | Composite adhesive tape |
US5246775A (en) | 1992-01-03 | 1993-09-21 | Loscuito Salvatore M | Self-sticking drywall tape |
AU4102493A (en) | 1992-03-16 | 1994-11-08 | Envirosurgical, Inc. | Surgery plume filter device and method of filtering |
US5167613A (en) | 1992-03-23 | 1992-12-01 | The Kendall Company | Composite vented wound dressing |
US5244457A (en) | 1992-03-23 | 1993-09-14 | The Kendall Company | Vented wound dressing |
SE500973C2 (en) | 1992-03-30 | 1994-10-10 | Moelnlycke Ab | Absorbent wound dressing |
FR2690617B1 (en) | 1992-04-29 | 1994-06-24 | Cbh Textile | TRANSPARENT ADHESIVE DRESSING. |
US5678564A (en) | 1992-08-07 | 1997-10-21 | Bristol Myers Squibb | Liquid removal system |
US5419769A (en) | 1992-10-23 | 1995-05-30 | Smiths Industries Medical Systems, Inc. | Suction systems |
GB2272645B8 (en) | 1992-11-23 | 2010-02-10 | Johnson & Johnson Medical | Wound dressing |
US5429590A (en) | 1992-12-01 | 1995-07-04 | Nitto Denko Corporation | Medical water-absorptive polymer and dressing for wound and medical bandage using the same |
DK169711B1 (en) | 1993-01-15 | 1995-01-23 | Coloplast As | A dressing |
DE4306478A1 (en) | 1993-03-02 | 1994-09-08 | Wolfgang Dr Wagner | Drainage device, in particular pleural drainage device, and drainage method |
DE4308649C2 (en) | 1993-03-18 | 1995-11-16 | Lohmann Gmbh & Co Kg | Medical plaster material and process for its production and its use |
US5342376A (en) | 1993-05-03 | 1994-08-30 | Dermagraphics, Inc. | Inserting device for a barbed tissue connector |
US6241747B1 (en) | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
NZ250994A (en) | 1993-05-27 | 1995-09-26 | Ndm Acquisition Corp | Wound dressing comprising a hydrogel layer bound to a porous backing layer which is bound to a thin film layer by adhesive |
US5344415A (en) | 1993-06-15 | 1994-09-06 | Deroyal Industries, Inc. | Sterile system for dressing vascular access site |
IE69360B1 (en) | 1993-07-01 | 1996-09-04 | Abbott Lab | Gelling treatment for suction drainage system |
US5458938A (en) | 1993-08-03 | 1995-10-17 | Minnesota Mining And Manufacturing Company | Mounting laminate having recessed adhesive areas |
US5437651A (en) | 1993-09-01 | 1995-08-01 | Research Medical, Inc. | Medical suction apparatus |
US5447492A (en) | 1993-12-20 | 1995-09-05 | New Dimensions In Medicine, Inc. | External fixation dressing for accommodating a retaining pin |
US5830201A (en) | 1994-01-14 | 1998-11-03 | Frederick W. George | Flushable diaper and method |
US5549584A (en) | 1994-02-14 | 1996-08-27 | The Kendall Company | Apparatus for removing fluid from a wound |
DE4406158A1 (en) | 1994-02-25 | 1995-08-31 | Rhein Chemie Rheinau Gmbh | Polyurethane elastomers with reduced gas permeability |
GB2288162B (en) | 1994-03-30 | 1997-11-26 | Harrison & Sons Ltd | Self-adhesive stamps |
AU698463B2 (en) | 1994-03-30 | 1998-10-29 | Bsn Medical, Inc. | Medical articles |
US6086995A (en) | 1994-05-13 | 2000-07-11 | Decora North America | Self-wound self-adhesive surface covering material |
US5607388A (en) | 1994-06-16 | 1997-03-04 | Hercules Incorporated | Multi-purpose wound dressing |
US5556375A (en) | 1994-06-16 | 1996-09-17 | Hercules Incorporated | Wound dressing having a fenestrated base layer |
US5664270A (en) | 1994-07-19 | 1997-09-09 | Kinetic Concepts, Inc. | Patient interface system |
PT1219311E (en) | 1994-08-22 | 2004-11-30 | Kci Licensing Inc | SUCCESS PUMP FOR USE WITH A DISCHARGEABLE LIQUID CONTAINER APPARATUS FOR WOUND FLUIDS |
US6228873B1 (en) | 1994-12-09 | 2001-05-08 | The Regents Of The University Of California | Method for enhancing outflow of aqueous humor in treatment of glaucoma |
SE503779C2 (en) | 1994-12-30 | 1996-09-02 | Moelnlycke Ab | Absorbent articles, comprising a receiving space in a storage layer, which upon wetting increases in extent perpendicular to the surface of the article and absorbent body |
DE69610819T2 (en) | 1995-01-26 | 2002-11-21 | Adv Med Solutions Ltd | WOUND DRESSING |
DE29504378U1 (en) | 1995-03-15 | 1995-09-14 | Mtg Medizinisch Tech Geraeteba | Electronically controlled low-vacuum pump for chest and wound drainage |
US5634893A (en) | 1995-04-24 | 1997-06-03 | Haemonetics Corporation | Autotransfusion apparatus |
US5611373A (en) | 1995-04-27 | 1997-03-18 | Handy & Harman Automotive Group, Inc. | Laminated fuel line and connector |
DE19517699C2 (en) | 1995-05-13 | 1999-11-04 | Wilhelm Fleischmann | Device for vacuum sealing a wound |
GB9523253D0 (en) | 1995-11-14 | 1996-01-17 | Mediscus Prod Ltd | Portable wound treatment apparatus |
US5736470A (en) | 1996-06-25 | 1998-04-07 | Omega Research, Inc. | Pressure sensitive adhesive article and method of making |
EP0928206B1 (en) | 1996-07-11 | 2004-04-14 | Coloplast A/S | A hydrocolloid wound gel |
JPH1097710A (en) | 1996-08-02 | 1998-04-14 | Nitto Denko Corp | Tacky adhesive type cleaning sheet, image forming material having cleaning member and cleaning method of image forming device |
US5776119A (en) | 1996-09-30 | 1998-07-07 | Bilbo; Sharon C. | Portable suction unit |
GB9701178D0 (en) | 1997-01-21 | 1997-03-12 | Smith & Nephew | Dressings |
WO1998040043A1 (en) | 1997-03-11 | 1998-09-17 | Jeneric/Pentron Incorporated | Catalyst and composition for silicone dental impression materials |
GB2324732B (en) | 1997-05-02 | 2001-09-26 | Johnson & Johnson Medical | Absorbent wound dressings |
US5878971A (en) | 1997-05-22 | 1999-03-09 | Minnesota Mining And Manufacturing Company | Perforated tab and tabbed tape rolls |
NL1006457C2 (en) | 1997-07-03 | 1999-01-05 | Polymedics N V | Drainage system to be used with an open wound, element used for applying a drainage pipe or hose and method for applying the drainage system. |
US6135116A (en) | 1997-07-28 | 2000-10-24 | Kci Licensing, Inc. | Therapeutic method for treating ulcers |
US6290685B1 (en) | 1998-06-18 | 2001-09-18 | 3M Innovative Properties Company | Microchanneled active fluid transport devices |
US6420622B1 (en) | 1997-08-01 | 2002-07-16 | 3M Innovative Properties Company | Medical article having fluid control film |
GB9719520D0 (en) | 1997-09-12 | 1997-11-19 | Kci Medical Ltd | Surgical drape and suction heads for wound treatment |
AU755496B2 (en) | 1997-09-12 | 2002-12-12 | Kci Licensing, Inc. | Surgical drape and suction head for wound treatment |
US6083616A (en) | 1997-09-19 | 2000-07-04 | Seal Products, Inc. | Nontack pressure activated adhesive |
US5919476A (en) | 1997-09-29 | 1999-07-06 | Pmt Corporation | Reinforced gel sheeting for scar treatment |
US6972141B1 (en) | 1997-12-12 | 2005-12-06 | 3M Innovative Properties Company | Removable adhesive tape laminate and separable fastener |
US5964252A (en) | 1997-12-18 | 1999-10-12 | Morgan Adhesives Company | Adhesive closure system with an abridged release liner |
US6071267A (en) | 1998-02-06 | 2000-06-06 | Kinetic Concepts, Inc. | Medical patient fluid management interface system and method |
US6458109B1 (en) | 1998-08-07 | 2002-10-01 | Hill-Rom Services, Inc. | Wound treatment apparatus |
US20030225355A1 (en) | 1998-10-01 | 2003-12-04 | Butler Charles E. | Composite material for wound repair |
CA2347135C (en) | 1998-10-02 | 2008-03-25 | 3M Innovative Properties Company | Laminated elastic composites |
US6488643B1 (en) | 1998-10-08 | 2002-12-03 | Kci Licensing, Inc. | Wound healing foot wrap |
US6736270B2 (en) | 1998-10-30 | 2004-05-18 | Varco I/P, Inc. | Glued screens for shale shakers |
DE69823518T2 (en) | 1998-11-19 | 2005-04-07 | Minnesota Mining And Mfg. Co., St. Paul | Adhesive tape for a diaper closure system |
US6627215B1 (en) | 1998-12-30 | 2003-09-30 | Oligos Etc. Inc. | Devices for improved wound management |
GB2348136B (en) | 1999-03-24 | 2003-06-04 | Johnson & Johnson Medical Ltd | Wound dressings having low adherency |
US6287316B1 (en) | 1999-03-26 | 2001-09-11 | Ethicon, Inc. | Knitted surgical mesh |
US7799004B2 (en) | 2001-03-05 | 2010-09-21 | Kci Licensing, Inc. | Negative pressure wound treatment apparatus and infection identification system and method |
US6856821B2 (en) | 2000-05-26 | 2005-02-15 | Kci Licensing, Inc. | System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure |
US6695823B1 (en) | 1999-04-09 | 2004-02-24 | Kci Licensing, Inc. | Wound therapy device |
US6228485B1 (en) | 1999-04-30 | 2001-05-08 | Flexipak Distributin, Llc | Venting tape |
US6991643B2 (en) | 2000-12-20 | 2006-01-31 | Usgi Medical Inc. | Multi-barbed device for retaining tissue in apposition and methods of use |
US6238762B1 (en) | 1999-09-03 | 2001-05-29 | Kittrich Corpn | Selectively tearable covering sheet |
US6495229B1 (en) | 1999-09-17 | 2002-12-17 | Avery Dennison Corporation | Pattern coated adhesive article |
US6638605B1 (en) | 1999-11-16 | 2003-10-28 | Allegiance Corporation | Intermittently bonded nonwoven disposable surgical laminates |
DE60039451D1 (en) | 1999-11-29 | 2008-08-21 | Hill Rom Services Inc | DEVICE FOR TREATING A WOUNCE |
US6764462B2 (en) | 2000-11-29 | 2004-07-20 | Hill-Rom Services Inc. | Wound treatment apparatus |
JP4330751B2 (en) | 2000-02-14 | 2009-09-16 | 富士フイルム株式会社 | Radiographic image acquisition method and apparatus, and cell interval detection method and apparatus therefor |
US6566575B1 (en) | 2000-02-15 | 2003-05-20 | 3M Innovative Properties Company | Patterned absorbent article for wound dressing |
US6548727B1 (en) | 2000-02-17 | 2003-04-15 | 3M Innovative Properties Company | Foam/film composite medical articles |
WO2001062328A1 (en) | 2000-02-24 | 2001-08-30 | Venetec International, Inc. | Universal catheter anchoring system |
ATE318566T1 (en) | 2000-03-10 | 2006-03-15 | 3M Innovative Properties Co | MEDICAL WOUND DRESSING WITH MULTIPLE ADHESIVES AND MANUFACTURING METHODS |
AU4748901A (en) | 2000-03-21 | 2001-10-03 | Kimberly Clark Co | Permanently wettable superabsorbents |
GB0011202D0 (en) | 2000-05-09 | 2000-06-28 | Kci Licensing Inc | Abdominal wound dressing |
BR0102116B1 (en) | 2000-05-10 | 2010-09-21 | component for a breathing circuit member. | |
ZA200209184B (en) | 2000-05-19 | 2004-02-11 | Kimberly Clark Co | Topsheet and transfer layer for an absorbent article. |
US7559324B2 (en) | 2000-06-21 | 2009-07-14 | Fisher & Paykel Healthcare Limited | Conduit with heated wick |
US20020090496A1 (en) | 2000-11-01 | 2002-07-11 | Sang-Hoon Kim | Adhesive tapes and adhesive note pads featuring non-adhesive sections |
US6685681B2 (en) | 2000-11-29 | 2004-02-03 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US6855135B2 (en) | 2000-11-29 | 2005-02-15 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
KR100770077B1 (en) | 2000-11-29 | 2007-10-24 | 브리스톨-마이어스 스퀴브 캄파니 | Light Stabilized Antimicrobial Materials |
US6541098B2 (en) | 2000-12-22 | 2003-04-01 | Avery Dennison Corporation | Three-dimensional flexible adhesive film structures |
ATE293464T1 (en) | 2001-02-08 | 2005-05-15 | Coloplast As | MEDICAL DRESSING COMPRISING AN ANTIMICROBIAL SILVER COMPOUND |
CA2438505A1 (en) | 2001-02-14 | 2002-09-12 | Genzyme Corporation | Altered peptide ligands |
US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7070584B2 (en) | 2001-02-20 | 2006-07-04 | Kci Licensing, Inc. | Biocompatible wound dressing |
US6540705B2 (en) | 2001-02-22 | 2003-04-01 | Core Products International, Inc. | Ankle brace providing upper and lower ankle adjustment |
US7236606B2 (en) | 2001-03-07 | 2007-06-26 | Harman International Industries, Incorporated | Sound system having a HF horn coaxially aligned in the mouth of a midrange horn |
US6695824B2 (en) | 2001-04-16 | 2004-02-24 | The United States Of America As Represented By The Secretary Of The Army | Wound dressing system |
US20020156410A1 (en) | 2001-04-19 | 2002-10-24 | Roger Lawry | Scar tissue treatment bandage and method |
US7645269B2 (en) | 2001-04-30 | 2010-01-12 | Kci Licensing, Inc. | Gradient wound treatment system and method |
DK1406567T3 (en) | 2001-07-12 | 2010-05-31 | Kci Medical Resources | Controlling the rate of vacuum change |
GB2377939B (en) | 2001-07-26 | 2005-04-20 | Johnson & Johnson Medical Ltd | Apertured sheet materials |
US7004915B2 (en) | 2001-08-24 | 2006-02-28 | Kci Licensing, Inc. | Negative pressure assisted tissue treatment system |
SE524111C2 (en) | 2001-09-28 | 2004-06-29 | Jan Otto Solem | A method and device for organ recovery |
US6787682B2 (en) | 2001-11-05 | 2004-09-07 | Hollister Incorporated | Absorbent foam wound dressing |
US6648862B2 (en) | 2001-11-20 | 2003-11-18 | Spheric Products, Ltd. | Personally portable vacuum desiccator |
GB2382305B (en) | 2001-11-23 | 2004-12-15 | Johnson & Johnson Medical Ltd | Absorbent wound dressings containing a hydrogel layer |
GB2382775B (en) | 2001-12-06 | 2005-05-25 | Johnson & Johnson Medical Ltd | Controlled release therapeutic wound dressings |
ATE352326T1 (en) | 2001-12-20 | 2007-02-15 | Noble Fiber Technologies Llc | WOUND DRESSINGS CONTAINING METALLIC SILVER |
US20050143694A1 (en) | 2002-02-15 | 2005-06-30 | Schmidt Nicolai M. | Wound care device |
US6749621B2 (en) | 2002-02-21 | 2004-06-15 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
US6693180B2 (en) | 2002-04-04 | 2004-02-17 | China Textile Institute | Composite sponge wound dressing made of β-Chitin and Chitosan and method for producing the same |
EP1496822B1 (en) | 2002-04-10 | 2018-08-29 | KCI Medical Resources | Access openings in vacuum bandage |
US20030212357A1 (en) | 2002-05-10 | 2003-11-13 | Pace Edgar Alan | Method and apparatus for treating wounds with oxygen and reduced pressure |
US20030225347A1 (en) | 2002-06-03 | 2003-12-04 | Argenta Louis C. | Directed tissue growth employing reduced pressure |
US20050224978A1 (en) | 2002-06-24 | 2005-10-13 | Kohichiro Kawate | Heat curable adhesive composition, article, semiconductor apparatus and method |
US20040002676A1 (en) | 2002-06-28 | 2004-01-01 | Siegwart Kathleen Ann | Adhesive bandage having a selectively placed layer |
DE10230121A1 (en) | 2002-07-04 | 2004-02-05 | Basf Ag | Process for making discrete patterns of adhesive coatings on a substrate |
US7846141B2 (en) | 2002-09-03 | 2010-12-07 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
GB2392836B (en) | 2002-09-11 | 2005-05-25 | Johnson & Johnson Medical Ltd | Wound dressings for the treatment of wound infection |
PT1536845E (en) | 2002-09-11 | 2007-06-01 | Johnson & Johnson Medical Ltd | Wound dressing materials comprising complexes of anionic polysaccharides with silver |
US6979324B2 (en) | 2002-09-13 | 2005-12-27 | Neogen Technologies, Inc. | Closed wound drainage system |
US7520872B2 (en) | 2002-09-13 | 2009-04-21 | Neogen Technologies, Inc. | Closed wound drainage system |
US7815616B2 (en) | 2002-09-16 | 2010-10-19 | Boehringer Technologies, L.P. | Device for treating a wound |
GB2393655B (en) | 2002-09-27 | 2005-08-24 | Johnson & Johnson Medical Ltd | Wound treatment device |
US7119247B2 (en) | 2002-10-22 | 2006-10-10 | George Medical, Llc | Dressing and a method for making and applying a dressing |
US8100872B2 (en) | 2002-10-23 | 2012-01-24 | Tyco Healthcare Group Lp | Medical dressing containing antimicrobial agent |
DE10249874A1 (en) | 2002-10-25 | 2004-05-06 | Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. | Anti-adhesive coating for finishing wound dressings |
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
AU2003295371A1 (en) | 2002-11-01 | 2004-06-07 | Otto Bock Healthcare Lp | Vacuum-suspended shoe |
US20040219337A1 (en) | 2002-11-25 | 2004-11-04 | Kappler, Inc. | Breathable blood and viral barrier fabric |
US7612248B2 (en) | 2002-12-19 | 2009-11-03 | 3M Innovative Properties Company | Absorbent medical articles |
US7976519B2 (en) | 2002-12-31 | 2011-07-12 | Kci Licensing, Inc. | Externally-applied patient interface system and method |
US6951553B2 (en) | 2002-12-31 | 2005-10-04 | Kci Licensing, Inc | Tissue closure treatment system and method with externally-applied patient interface |
CA2510977C (en) | 2002-12-31 | 2012-09-18 | Ossur Hf | Wound dressing comprising an absorbent core with a plurality of receptacles formed therein |
US7419483B2 (en) | 2003-02-07 | 2008-09-02 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California | Surgical drain with positioning and protective features |
US7972616B2 (en) | 2003-04-17 | 2011-07-05 | Nanosys, Inc. | Medical device applications of nanostructured surfaces |
US7351217B2 (en) | 2003-05-23 | 2008-04-01 | Yvette Scherpenborg | Thermal compressive aerating bandage and methods of use relating to same |
IES20030443A2 (en) | 2003-06-16 | 2004-12-01 | Fraudhalt Ltd | A method and apparatus for determining if an optical disk originated from a valid source |
AU2004248898B2 (en) | 2003-06-23 | 2010-03-18 | Beiersdorf Ag | Antimicrobial wounddressing |
US20050158539A1 (en) | 2003-06-25 | 2005-07-21 | Andover Coated Products, Inc. | Pressure-sensitive adhesive tapes |
US20060154546A1 (en) | 2003-06-25 | 2006-07-13 | Andover Coated Products, Inc. | Air permeable pressure-sensitive adhesive tapes |
US20050034731A1 (en) | 2003-08-13 | 2005-02-17 | Rousseau Robert A. | Surgical wound closure device |
US7942866B2 (en) | 2003-08-28 | 2011-05-17 | Boehringer Technologies, L.P. | Device for treating a wound |
US20050054998A1 (en) | 2003-09-05 | 2005-03-10 | Poccia John F. | Absorbent article |
US20050065484A1 (en) | 2003-09-10 | 2005-03-24 | Watson Richard L. | Wound healing apparatus with bioabsorbable material and suction tubes |
US7396975B2 (en) | 2003-09-17 | 2008-07-08 | Ossur Hf | Wound dressing and method for manufacturing the same |
CA2576040A1 (en) | 2003-10-21 | 2005-04-28 | Bioartificial Gel Technologies Inc. | Hydrogel-containing medical articles and methods of using and making the same |
US20060083776A1 (en) | 2003-10-27 | 2006-04-20 | Bott Richard R | Preparations for topical application and methods of delivering an active agent to a substrate |
GB0325120D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with actives |
GB0325129D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus in situ |
GB0325126D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with heat |
EP1543727B1 (en) | 2003-12-19 | 2007-03-21 | Kraft Foods R & D, Inc. Zweigniederlassung München | Wax-coated cheese |
AU2004308415A1 (en) | 2003-12-23 | 2005-07-14 | Hemcon, Inc. | Tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chistosan |
JP4303143B2 (en) | 2003-12-25 | 2009-07-29 | ユニ・チャーム株式会社 | Panty liner |
US7137390B2 (en) | 2004-01-23 | 2006-11-21 | Ric Investments, Llc. | Liquid absorbing filter assembly and system using same |
US20050163978A1 (en) | 2004-01-27 | 2005-07-28 | Esben Strobech | Article having a surface showing adhesive properties |
CA2560840C (en) | 2004-03-24 | 2014-05-06 | Corium International, Inc. | Transdermal delivery device |
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US10058642B2 (en) | 2004-04-05 | 2018-08-28 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
GB0409293D0 (en) | 2004-04-27 | 2004-06-02 | Smith & Nephew | Apparatus with flow stress |
US8529548B2 (en) | 2004-04-27 | 2013-09-10 | Smith & Nephew Plc | Wound treatment apparatus and method |
US20050277860A1 (en) | 2004-06-14 | 2005-12-15 | Jentec, Inc. | Extended stay-on wound dressing |
GB2415382A (en) | 2004-06-21 | 2005-12-28 | Johnson & Johnson Medical Ltd | Wound dressings for vacuum therapy |
WO2006020174A2 (en) | 2004-07-16 | 2006-02-23 | Polyremedy, Inc. | Wound dressing and apparatus for manufacturing |
DE202004017052U1 (en) | 2004-11-02 | 2005-06-09 | Riesinger, Birgit | Device for wound treatment using negative pressure |
DE202004018245U1 (en) | 2004-11-24 | 2005-07-07 | Riesinger, Birgit | Drainage device for treating wounds using reduced pressure has absorption body with layer(s) of textile section enriched with super-absorbents enclosed by liquid transmissive sleeve; absorbed wound secretions remain in absorption body |
US7161056B2 (en) | 2005-01-28 | 2007-01-09 | Ossur Hf | Wound dressing and method for manufacturing the same |
ATE485962T1 (en) | 2005-03-24 | 2010-11-15 | Ems Chemie Ag | USE OF A PIPE SYSTEM FOR FLUIDS WITH VOLATILE COMPONENTS |
GB2425487A (en) | 2005-04-26 | 2006-11-01 | Dow Corning | Wound dressing and method of preparation |
WO2006127905A2 (en) | 2005-05-24 | 2006-11-30 | Chrono Therapeutics, Inc. | Portable drug delivery device |
AU2006263650B2 (en) | 2005-06-29 | 2012-03-15 | Applied Tissue Technologies, Llc | Wound chamber for limb |
US20070027414A1 (en) | 2005-07-28 | 2007-02-01 | Integra Lifesciences Corporation | Laminar construction negative pressure wound dressing including bioabsorbable material |
US7252694B2 (en) | 2005-08-05 | 2007-08-07 | 3M Innovative Properties Company | Abrasive article and methods of making same |
US8240187B2 (en) | 2005-08-16 | 2012-08-14 | Oridion Medical (1987) Ltd. | Breath sampling device and method for using same |
CN101257875A (en) | 2005-09-06 | 2008-09-03 | 泰科保健集团有限合伙公司 | Self contained wound dressing with micropump |
JP5005916B2 (en) | 2005-12-09 | 2012-08-22 | スリーエム イノベイティブ プロパティズ カンパニー | Release agent composition for skin adhesive |
DE202005019670U1 (en) | 2005-12-14 | 2006-04-27 | Riesinger, Birgit | Wound treatment device with elastically deformable negative pressure generating element |
US7622629B2 (en) | 2005-12-15 | 2009-11-24 | Aalnex, Inc. | Wound shield for exudate management |
DE202006007877U1 (en) | 2006-01-25 | 2006-07-27 | Riesinger, Birgit | Prefabricated wound dressing with superabsorber |
US8795730B2 (en) | 2006-01-31 | 2014-08-05 | David John Vachon | Compositions and methods for promoting the healing of tissue of multicellular organisms |
US20090005746A1 (en) | 2006-02-02 | 2009-01-01 | Brian Nielsen | Suction System |
AU2007212480B2 (en) | 2006-02-06 | 2010-04-29 | Solventum Intellectual Properties Company | Systems and methods for improved connection to wound dressings in conjunction with reduced pressure wound treatment systems |
NL1031112C2 (en) | 2006-02-09 | 2007-08-10 | Multifoil Bv | Tape and method for manufacturing thereof. |
JP2007254515A (en) | 2006-03-22 | 2007-10-04 | Lintec Corp | Pressure-sensitive adhesive sheet for application to skin |
GB0606661D0 (en) | 2006-04-03 | 2006-05-10 | Brightwake Ltd | Improvements relating to dressings |
DE102006017194B4 (en) | 2006-04-12 | 2010-11-04 | Birgit Riesinger | Fluid-permeable primary dressing |
BRPI0601479A (en) * | 2006-05-03 | 2007-12-18 | Johnson & Johnson Ind Ltda | adhesive bandage |
US7615036B2 (en) | 2006-05-11 | 2009-11-10 | Kalypto Medical, Inc. | Device and method for wound therapy |
US7779625B2 (en) | 2006-05-11 | 2010-08-24 | Kalypto Medical, Inc. | Device and method for wound therapy |
EP2032214B1 (en) | 2006-06-07 | 2017-12-06 | Theravent, Inc. | Layered nasal devices |
GB2439928A (en) | 2006-07-13 | 2008-01-16 | Ethicon Inc | Hydrogel wound dressings exhibiting reduced fiber losses |
US20090326488A1 (en) | 2006-07-24 | 2009-12-31 | Klaus Budig | Canister, Suction Device and System For Vacuum Treatment Securing a Fixed Treatment Pressure |
US7504550B2 (en) | 2006-08-31 | 2009-03-17 | Kimberly-Clark Worldwide, Inc. | Conductive porous materials |
DE602007004546D1 (en) | 2006-09-28 | 2010-03-18 | Tyco Healthcare | Portable wound therapy system |
DE102006047041A1 (en) | 2006-10-02 | 2008-04-10 | Birgit Riesinger | Areal absorbent body |
CA2664285A1 (en) | 2006-10-03 | 2008-07-10 | Arsenal Medical, Inc. | Articles and methods for tissue repair |
SE0602064L (en) | 2006-10-03 | 2008-04-04 | Moelnlycke Health Care Ab | Wound dressing with pressure distributing hose inlet |
CN110251740A (en) | 2006-10-13 | 2019-09-20 | 凯希特许有限公司 | For providing the reduced pressure delivery system for the treatment of to lower severity wound |
SE0602303L (en) | 2006-11-01 | 2008-05-02 | Moelnlycke Health Care Ab | The operating sheet with easy bendable edge and stiffening edge layer |
ES2361025T3 (en) | 2006-11-07 | 2011-06-13 | Paul Hartmann Ag | ABSORBENT BOTTOM OF MULTIPLE LAYERS WITH A HYDROPHYLE LAYER OF CONTACT WITH THE WOUND. |
DE202007019572U1 (en) | 2006-12-06 | 2013-12-02 | Weinmann Geräte für Medizin GmbH + Co. KG | Respiratory mask with a filling body |
US7674345B2 (en) | 2006-12-08 | 2010-03-09 | 3M Innovative Properties Company | Adhesive articles with discontinuities and methods of making the same |
US7740928B2 (en) | 2007-01-22 | 2010-06-22 | Building Materials Investment Corporation | Peel and stick stretch wrap |
WO2008100437A1 (en) | 2007-02-09 | 2008-08-21 | Kci Licensing Inc. | A breathable interface system for topical reduced pressure |
US8267908B2 (en) | 2007-02-09 | 2012-09-18 | Kci Licensing, Inc. | Delivery tube, system, and method for storing liquid from a tissue site |
MX2009008397A (en) | 2007-02-09 | 2009-10-28 | Kci Licensing Inc | System and method for managing reduced pressure at a tissue site. |
WO2008104609A1 (en) | 2007-03-01 | 2008-09-04 | Coloplast A/S | Pressure-distributing elements for use with negative pressure therapy |
EP2129409B2 (en) | 2007-03-14 | 2021-11-24 | The Board of Trustees of the Leland Stanford Junior University | Devices for application of reduced pressure therapy |
US8083712B2 (en) | 2007-03-20 | 2011-12-27 | Neogen Technologies, Inc. | Flat-hose assembly for wound drainage system |
US20080269657A1 (en) | 2007-04-26 | 2008-10-30 | Isense Corporation | Adhesive overbandage |
DE102008020553A1 (en) | 2007-04-29 | 2008-10-30 | Iskia Gmbh & Co.Kg | Flat drainage for wound treatment |
WO2008154158A2 (en) | 2007-05-24 | 2008-12-18 | Applied Tissue Technologies Llc | Woundtreatment device employing negative pressure |
US20100168633A1 (en) | 2007-06-04 | 2010-07-01 | Chaabane Bougherara | Method for manufacturing two different patterned adhesive layers simultaneously |
WO2008148797A1 (en) | 2007-06-04 | 2008-12-11 | Coloplast A/S | A method for manufacturing a net patterned adhesive layer |
GB0710846D0 (en) | 2007-06-06 | 2007-07-18 | Bristol Myers Squibb Co | A wound dressing |
SE531259C2 (en) | 2007-06-27 | 2009-02-03 | Moelnlycke Health Care Ab | Device for treating reduced pressure ulcers |
US9539149B2 (en) | 2007-07-13 | 2017-01-10 | Ut-Battelle, Llc | Superhydrophobic, diatomaceous earth comprising bandages and method of making the same |
US20090025724A1 (en) | 2007-07-16 | 2009-01-29 | Herron Jr Roy Howard | System for removal of water from a hose and the hygroscopic hose utilized |
GB2452720A (en) | 2007-09-11 | 2009-03-18 | Ethicon Inc | Wound dressing with an antimicrobial absorbent layer and an apertured cover sheet |
US20090088719A1 (en) | 2007-09-27 | 2009-04-02 | Tyco Healthcare Retail Service Ag | Absorbent article having integral stretch panels and methods for making the same |
WO2009066106A1 (en) | 2007-11-21 | 2009-05-28 | Smith & Nephew Plc | Wound dressing |
AU2008327660B2 (en) | 2007-11-21 | 2014-02-13 | Smith & Nephew Plc | Wound dressing |
US20130096518A1 (en) | 2007-12-06 | 2013-04-18 | Smith & Nephew Plc | Wound filling apparatuses and methods |
GB2455962A (en) | 2007-12-24 | 2009-07-01 | Ethicon Inc | Reinforced adhesive backing sheet, for plaster |
US8377017B2 (en) | 2008-01-03 | 2013-02-19 | Kci Licensing, Inc. | Low-profile reduced pressure treatment system |
WO2009089016A1 (en) | 2008-01-08 | 2009-07-16 | Southeastern Medical Technologies, Llc | A methods and apparatuses for the treatment of wounds with pressures altered from atmospheric |
US20090216204A1 (en) | 2008-02-27 | 2009-08-27 | Sai Bhavaraju | Auto-replenishing, wound-dressing apparatus and method |
AU2009219126B2 (en) | 2008-02-27 | 2014-07-31 | Kci Licensing Inc. | System and method for healing a wound at a tissue site |
CA2715843A1 (en) | 2008-03-05 | 2009-09-11 | Kci Licensing Inc. | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
US8449508B2 (en) | 2008-03-05 | 2013-05-28 | Kci Licensing, Inc. | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
US8021347B2 (en) | 2008-07-21 | 2011-09-20 | Tyco Healthcare Group Lp | Thin film wound dressing |
US8298200B2 (en) | 2009-06-01 | 2012-10-30 | Tyco Healthcare Group Lp | System for providing continual drainage in negative pressure wound therapy |
US9199012B2 (en) | 2008-03-13 | 2015-12-01 | Smith & Nephew, Inc. | Shear resistant wound dressing for use in vacuum wound therapy |
US20090234306A1 (en) | 2008-03-13 | 2009-09-17 | Tyco Healthcare Group Lp | Vacuum wound therapy wound dressing with variable performance zones |
WO2009114775A1 (en) | 2008-03-13 | 2009-09-17 | Kci Licensing, Inc. | System and method for reduced pressure charging |
SE533170C2 (en) | 2008-04-09 | 2010-07-13 | Moelnlycke Health Care Ab | Device for treating wounds with suppression |
US8007481B2 (en) | 2008-07-17 | 2011-08-30 | Tyco Healthcare Group Lp | Subatmospheric pressure mechanism for wound therapy system |
US8048046B2 (en) | 2008-05-21 | 2011-11-01 | Tyco Healthcare Group Lp | Wound therapy system with housing and canister support |
US8257326B2 (en) | 2008-06-30 | 2012-09-04 | Tyco Healthcare Group Lp | Apparatus for enhancing wound healing |
EP2296598B1 (en) | 2008-07-07 | 2014-12-24 | Laboratoire Medidom S.A. | Temperature reducing, healing wound dressing |
WO2010011148A1 (en) | 2008-07-24 | 2010-01-28 | Frederick George | Negative pressure wound therapy system |
US20100030170A1 (en) | 2008-08-01 | 2010-02-04 | Keith Alan Keller | Absorptive Pad |
EP2318065B1 (en) | 2008-08-05 | 2018-09-26 | Mölnlycke Health Care AB | Component for securing attachment of a medical device to skin |
US8251979B2 (en) | 2009-05-11 | 2012-08-28 | Tyco Healthcare Group Lp | Orientation independent canister for a negative pressure wound therapy device |
US8216198B2 (en) | 2009-01-09 | 2012-07-10 | Tyco Healthcare Group Lp | Canister for receiving wound exudate in a negative pressure therapy system |
CN105034473A (en) | 2008-09-16 | 2015-11-11 | 株式会社朝日橡胶 | Bonded object of three-dimensional silicone rubber |
MX2011004415A (en) | 2008-10-29 | 2011-05-31 | Kci Licensing Inc | Reduced-pressure, wound-closure and treatment systems and methods. |
US20100121298A1 (en) | 2008-11-10 | 2010-05-13 | Tredegar Film Products Corporation | Transfer layer for absorbent article |
EP3388093B1 (en) | 2008-11-14 | 2020-05-20 | KCI Licensing, Inc. | Fluid pouch, system, and method for storing fluid from a tissue site |
BRPI0916007A2 (en) | 2008-11-19 | 2015-11-03 | Kci Licensing Inc | "dynamic reduced pressure treatment system for treating a tissue site in a patient, method of producing a dynamic reduced pressure treatment system for treating a tissue site in a patient, method for treating a tissue site in a patient, and , reduced pressure application member " |
GB0821702D0 (en) | 2008-11-28 | 2008-12-31 | Brightwake Ltd | Process |
DE102008063229A1 (en) | 2008-12-19 | 2010-07-01 | Dehn, Michael C. | Felt material with barrier function and component made of felt |
US8162907B2 (en) | 2009-01-20 | 2012-04-24 | Tyco Healthcare Group Lp | Method and apparatus for bridging from a dressing in negative pressure wound therapy |
US9689512B2 (en) | 2009-02-20 | 2017-06-27 | Hobart Brothers Company | Air hose delivery assembly with inner liner |
US9067035B2 (en) | 2009-03-03 | 2015-06-30 | Oridion Medical (1987) Ltd. | Drying substances, preparation and use thereof |
NO330398B1 (en) | 2009-03-03 | 2011-04-04 | Padtech As | Fluid barrier pad |
US20100267302A1 (en) | 2009-04-17 | 2010-10-21 | 3M Innovative Properties Company | Silicone gel adhesive construction |
TW201038258A (en) | 2009-04-21 | 2010-11-01 | Fortune Medical Instr Corp | Silica gel patch of rectifying scar |
US8377015B2 (en) | 2009-04-24 | 2013-02-19 | Alcare Co., Ltd. | Wound dressing and method for producing it |
US8946499B2 (en) | 2009-04-27 | 2015-02-03 | Avery Dennison Corporation | Systems, methods and materials for delivery and debonding on demand |
SE533841C2 (en) | 2009-06-15 | 2011-02-01 | Moelnlycke Health Care Ab | Wound dressing with high fluid handling capacity |
US20100324516A1 (en) | 2009-06-18 | 2010-12-23 | Tyco Healthcare Group Lp | Apparatus for Vacuum Bridging and/or Exudate Collection |
US8469936B2 (en) * | 2009-07-15 | 2013-06-25 | Kci Licensing, Inc. | Reduced-pressure dressings, systems, and methods employing desolidifying barrier layers |
WO2011043786A1 (en) | 2009-09-17 | 2011-04-14 | Zipline Medical, Inc. | Rapid closing surgical closure device |
US8529526B2 (en) | 2009-10-20 | 2013-09-10 | Kci Licensing, Inc. | Dressing reduced-pressure indicators, systems, and methods |
CA3106017A1 (en) | 2009-12-22 | 2011-06-30 | Fisher & Paykel Healthcare Limited | Components for medical circuits |
US8721606B2 (en) | 2010-03-11 | 2014-05-13 | Kci Licensing, Inc. | Dressings, systems, and methods for treating a tissue site |
US8814842B2 (en) | 2010-03-16 | 2014-08-26 | Kci Licensing, Inc. | Delivery-and-fluid-storage bridges for use with reduced-pressure systems |
US20110257617A1 (en) | 2010-04-02 | 2011-10-20 | Franklin Amie B | Therapeutic Diffusion Hydrocolloid Wound Dressings |
CA2794956C (en) | 2010-04-03 | 2017-05-02 | Praful Doshi | Medical devices including medicaments and methods of making and using same |
DE102010014010A1 (en) | 2010-04-03 | 2011-10-06 | Birgit Riesinger | Wound care article adapted to different flow rates of the wound exudate |
US8702665B2 (en) | 2010-04-16 | 2014-04-22 | Kci Licensing, Inc. | Reduced-pressure sources, systems, and methods employing a polymeric, porous, hydrophobic material |
US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
GB201006986D0 (en) | 2010-04-27 | 2010-06-09 | Smith & Nephew | Wound dressing |
US20110281084A1 (en) | 2010-05-14 | 2011-11-17 | Tim Ashwell | Variable bond strength adhesive tape |
TWI524906B (en) | 2010-06-01 | 2016-03-11 | 瑞光股份有限公司 | Surface sheet material for wound dressing and wound dressing |
WO2011162862A1 (en) | 2010-06-23 | 2011-12-29 | Convatec Technologies Inc. | Wound dressing |
US9265665B2 (en) | 2010-07-19 | 2016-02-23 | Kci Licensing, Inc. | Inflatable off-loading wound dressing assemblies, systems, and methods |
US20120019031A1 (en) | 2010-07-21 | 2012-01-26 | Gregory Robert Bessert | Wheelchair Cover |
US20120040131A1 (en) | 2010-08-10 | 2012-02-16 | Speer Dwaine D | Composite Panel Having Perforated Foam Core |
JP5279777B2 (en) | 2010-08-28 | 2013-09-04 | 三菱電機株式会社 | Synchronous motor rotor |
US8579872B2 (en) | 2010-10-27 | 2013-11-12 | Kci Licensing, Inc. | Reduced-pressure systems, dressings, and methods employing a wireless pump |
US8986269B2 (en) | 2010-11-11 | 2015-03-24 | Ulcerx Medical Inc. | Wound leakage vacuum collection device |
JP5833134B2 (en) | 2010-12-08 | 2015-12-16 | コンバテック・テクノロジーズ・インコーポレイテッドConvatec Technologies Inc | Method and system for removing exudate from a wound site |
GB2488749A (en) | 2011-01-31 | 2012-09-12 | Systagenix Wound Man Ip Co Bv | Laminated silicone coated wound dressing |
US9107990B2 (en) | 2011-02-14 | 2015-08-18 | Kci Licensing, Inc. | Reduced-pressure dressings, systems, and methods for use with linear wounds |
US20120258271A1 (en) | 2011-04-08 | 2012-10-11 | Pointil Systems Inc. | Methods for reducing tack of pressure-sensitive adhesive |
WO2012142002A1 (en) | 2011-04-12 | 2012-10-18 | Kci Licensing, Inc. | Evaporative fluid pouch and systems for use with body fluids |
FR2974005B1 (en) | 2011-04-15 | 2014-05-02 | Urgo Lab | THIN ABSORBENT THIN ADHESIVE DRESSING, ITS USES FOR THE TREATMENT OF CHRONIC WOUNDS |
GB201106491D0 (en) | 2011-04-15 | 2011-06-01 | Systagenix Wound Man Ip Co Bv | Patterened silicone coating |
RU2572005C2 (en) | 2011-04-21 | 2015-12-27 | СМИТ ЭНД НЕФЬЮ ПиЭлСи | Control of blockage |
GB201108229D0 (en) | 2011-05-17 | 2011-06-29 | Smith & Nephew | Tissue healing |
US20120310186A1 (en) | 2011-06-06 | 2012-12-06 | Tyco Healthcare Group Lp | Dressings and Related Methods Therefor |
EP2723286B2 (en) | 2011-06-24 | 2021-10-13 | KCI Licensing, Inc. | Reduced-pressure dressings employing tissue-fixation elements |
IN2014CN00862A (en) | 2011-07-08 | 2015-04-03 | Contra Vision Ltd | |
US20140142490A1 (en) | 2011-07-08 | 2014-05-22 | Mölnlycke Health Care Ab | Self-adhesive wound care product |
AU2012287136B2 (en) | 2011-07-26 | 2016-11-17 | Solventum Intellectual Properties Company | Systems and methods for treating a tissue site with reduced pressure involving a reduced-pressure interface having a multi-lumen conduit for contacting a manifold |
EP2561844B1 (en) | 2011-08-23 | 2016-01-20 | Zodiac Coating | Verbundmaterial, das eine textile Wirkwarenunterlage umfasst |
WO2013039622A2 (en) | 2011-09-14 | 2013-03-21 | Kci Licensing, Inc. | Reduced-pressure systems and methods employing a leak-detection member |
WO2013064831A1 (en) | 2011-11-01 | 2013-05-10 | Brightwake Limited | Wound dressings, and yarn useful therein |
US9101508B2 (en) | 2011-12-07 | 2015-08-11 | Esmaeil Mirzaei | Electro spun nanofibrous wound dressing and a method of synthesizing the same |
EP2790623B1 (en) | 2011-12-16 | 2023-05-31 | 3M Innovative Properties Company | Sealing systems and methods employing a switchable drape |
EP3005997A1 (en) * | 2011-12-16 | 2016-04-13 | KCI Licensing, Inc. | Releasable medical drapes |
ES2606612T3 (en) | 2011-12-21 | 2017-03-24 | The Procter & Gamble Company | Container comprising a removable label |
EP2636417B1 (en) | 2012-03-05 | 2017-04-26 | Lohmann & Rauscher GmbH | Wound treatment assembly and covering device for same |
US9035122B2 (en) | 2012-03-05 | 2015-05-19 | Polyremedy, Inc. | Wound dressing inhibiting lateral diffusion of absorbed exudate |
CN104271163A (en) | 2012-03-12 | 2015-01-07 | 博斯蒂克股份公司 | Breathable self-adhesive articles |
WO2013149078A1 (en) | 2012-03-28 | 2013-10-03 | Kci Licensing, Inc. | Reduced-pressure systems, dressings, and methods facilitating separation of electronic and clinical component parts |
US9220646B2 (en) | 2012-03-30 | 2015-12-29 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with improved stain decolorization |
WO2013175306A2 (en) | 2012-05-23 | 2013-11-28 | Smith & Nephew Plc | Apparatuses and methods for negative pressure wound therapy |
US9122143B2 (en) | 2012-06-07 | 2015-09-01 | Mindflow Llc | Dynamically variable graphic material using electrostatically attracted particles |
CN104487033B (en) | 2012-07-30 | 2018-06-15 | 凯希特许有限公司 | Decompression absorbability for treating tissue site applies part, system and manufactures the method for applying part |
DK2879636T3 (en) | 2012-08-01 | 2017-06-19 | Smith & Nephew | Wound dressing |
WO2014022548A1 (en) | 2012-08-03 | 2014-02-06 | Kci Licensing, Inc. | Interfaces, systems, and methods for use in reduced pressure tissue treatment |
US20150202354A1 (en) | 2012-09-04 | 2015-07-23 | Integrated Healing Technolgies, LLC | Wound Dressing |
US9345869B2 (en) | 2012-10-11 | 2016-05-24 | Owl Manor Medical, Llc | Oxygen diffusive wound dressings and methods of manufacturing and use |
US9572968B2 (en) | 2012-10-11 | 2017-02-21 | Hanuman Pelican, Inc. | Compressive oxygen diffusive wound dressings |
EP3092990B1 (en) | 2012-11-16 | 2020-03-11 | KCI Licensing, Inc. | Method of manufacturing a medical drape with pattern adhesive layers |
DE102013100157A1 (en) | 2013-01-09 | 2014-07-10 | Birgit Riesinger | Liquid-permeable primary dressing with a silicone coating |
EP2945584B1 (en) | 2013-01-16 | 2016-07-20 | KCI Licensing, Inc. | Dressing with asymmetric absorbent core for negative pressure wound therapy |
EP3238674B1 (en) | 2013-03-14 | 2019-01-30 | KCI Licensing, Inc. | Absorbent dressing with hybrid drape |
BR112015020855A2 (en) | 2013-03-15 | 2017-07-18 | Smith & Nephew | wound dressing and treatment method |
JP6808323B2 (en) | 2013-03-15 | 2021-01-06 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Wound dressing sealant and its use |
GB2512841B (en) | 2013-04-08 | 2020-07-15 | Brightwake Ltd | Absorbent wound dressings |
US20140336557A1 (en) | 2013-05-10 | 2014-11-13 | Biovation Ii, Llc | Biopolymer multi-layer multi-functional medical dressing and method of making same |
US20140352073A1 (en) | 2013-06-04 | 2014-12-04 | Welspun India Limited | Semi-absorbent, semi-resistant, breathable fabric |
US10342891B2 (en) | 2013-09-19 | 2019-07-09 | Medline Industries, Inc. | Wound dressing containing saccharide and collagen |
WO2015065616A1 (en) | 2013-10-30 | 2015-05-07 | Kci Licensing, Inc. | Dressing with sealing and retention intereface |
EP3527237B1 (en) | 2013-10-30 | 2020-09-09 | KCI Licensing, Inc. | Absorbent conduit and system |
DE202014100383U1 (en) | 2014-01-29 | 2015-02-02 | Birgit Riesinger | Wound care article comprising a material with high restoring force |
EP3479803B1 (en) | 2014-02-28 | 2021-03-31 | 3M Innovative Properties Company | Hybrid drape having a gel-coated perforated mesh |
EP3349807B1 (en) | 2015-09-17 | 2021-02-24 | 3M Innovative Properties Company | Hybrid silicone and acrylic adhesive cover for use with wound treatment |
-
2014
- 2014-10-17 WO PCT/US2014/061251 patent/WO2015065742A1/en active Application Filing
- 2014-10-17 EP EP14795899.5A patent/EP3062753B1/en active Active
- 2014-10-17 US US14/517,521 patent/US10946124B2/en active Active
- 2014-10-17 EP EP18203603.8A patent/EP3470030A1/en active Pending
-
2019
- 2019-02-27 US US16/287,862 patent/US20190192750A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111579144A (en) * | 2020-04-08 | 2020-08-25 | 中国海洋大学 | Synchronous measurement device and method for double-dispersion interface pressure in emulsion and application |
Also Published As
Publication number | Publication date |
---|---|
EP3062753B1 (en) | 2018-11-21 |
EP3062753A1 (en) | 2016-09-07 |
WO2015065742A1 (en) | 2015-05-07 |
WO2015065742A9 (en) | 2015-06-25 |
US20150119834A1 (en) | 2015-04-30 |
US10946124B2 (en) | 2021-03-16 |
EP3470030A1 (en) | 2019-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190192750A1 (en) | Hybrid Sealing Tape | |
US20230201042A1 (en) | Hybrid drape having a gel-coated perforated mesh | |
US20200397620A1 (en) | Hybrid silicone and acrylic adhesive cover for use with wound treatment | |
US11576821B2 (en) | Methods for manufacturing and assembling dual material tissue interface for negative-pressure therapy | |
US20200268561A1 (en) | High-density evaporative bridge dressing | |
EP3813750B1 (en) | Release liner with edge protection | |
EP3669842B1 (en) | Medical drape with pattern adhesive layers | |
EP3531998B1 (en) | Hybrid drape | |
US20200246190A1 (en) | Drape strip having selectable adhesive | |
US20180353338A1 (en) | Customizable Composite Dressings For Improved Granulation And Reduced Maceration With Negative-Pressure Treatment | |
WO2023079382A1 (en) | Negative pressure wound therapy dressing with isolated super absorbent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: KCI LICENSING, INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LOCKE, CHRISTOPHER BRIAN;ROBINSON, TIMOTHY MARK;SIGNING DATES FROM 20141002 TO 20141009;REEL/FRAME:048463/0959 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |